WO2021210956A1 - Antiviral filter medium, and air filter unit and air conditioner including same - Google Patents

Antiviral filter medium, and air filter unit and air conditioner including same Download PDF

Info

Publication number
WO2021210956A1
WO2021210956A1 PCT/KR2021/004826 KR2021004826W WO2021210956A1 WO 2021210956 A1 WO2021210956 A1 WO 2021210956A1 KR 2021004826 W KR2021004826 W KR 2021004826W WO 2021210956 A1 WO2021210956 A1 WO 2021210956A1
Authority
WO
WIPO (PCT)
Prior art keywords
antiviral
filter medium
fiber
component
surfactant
Prior art date
Application number
PCT/KR2021/004826
Other languages
French (fr)
Korean (ko)
Inventor
장선호
조준근
이승훈
Original Assignee
주식회사 아모그린텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아모그린텍 filed Critical 주식회사 아모그린텍
Publication of WO2021210956A1 publication Critical patent/WO2021210956A1/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D39/00Filtering material for liquid or gaseous fluids
    • B01D39/14Other self-supporting filtering material ; Other filtering material
    • B01D39/16Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • B01D39/1607Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous
    • B01D39/1623Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous of synthetic origin
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A41D13/1192Protective face masks, e.g. for surgical use, or for use in foul atmospheres with antimicrobial agent
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/10Impermeable to liquids, e.g. waterproof; Liquid-repellent
    • A41D31/102Waterproof and breathable
    • AHUMAN NECESSITIES
    • A41WEARING APPAREL
    • A41DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D31/00Materials specially adapted for outerwear
    • A41D31/04Materials specially adapted for outerwear characterised by special function or use
    • A41D31/30Antimicrobial, e.g. antibacterial
    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62BDEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B18/00Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort
    • A62B18/02Masks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D39/00Filtering material for liquid or gaseous fluids
    • B01D39/14Other self-supporting filtering material ; Other filtering material
    • B01D39/16Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D39/00Filtering material for liquid or gaseous fluids
    • B01D39/14Other self-supporting filtering material ; Other filtering material
    • B01D39/16Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres
    • B01D39/1607Other self-supporting filtering material ; Other filtering material of organic material, e.g. synthetic fibres the material being fibrous
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/22Yarns or threads characterised by constructional features, e.g. blending, filament/fibre
    • D02G3/38Threads in which fibres, filaments, or yarns are wound with other yarns or filaments, e.g. wrap yarns, i.e. strands of filaments or staple fibres are wrapped by a helically wound binder yarn
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/44Yarns or threads characterised by the purpose for which they are designed
    • DTEXTILES; PAPER
    • D02YARNS; MECHANICAL FINISHING OF YARNS OR ROPES; WARPING OR BEAMING
    • D02GCRIMPING OR CURLING FIBRES, FILAMENTS, THREADS, OR YARNS; YARNS OR THREADS
    • D02G3/00Yarns or threads, e.g. fancy yarns; Processes or apparatus for the production thereof, not otherwise provided for
    • D02G3/44Yarns or threads characterised by the purpose for which they are designed
    • D02G3/449Yarns or threads with antibacterial properties
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2239/00Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/02Types of fibres, filaments or particles, self-supporting or supported materials
    • B01D2239/025Types of fibres, filaments or particles, self-supporting or supported materials comprising nanofibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2239/00Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04Additives and treatments of the filtering material
    • B01D2239/0435Electret
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2239/00Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04Additives and treatments of the filtering material
    • B01D2239/0442Antimicrobial, antibacterial, antifungal additives
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2239/00Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/06Filter cloth, e.g. knitted, woven non-woven; self-supported material
    • B01D2239/065More than one layer present in the filtering material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2239/00Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/12Special parameters characterising the filtering material
    • B01D2239/1233Fibre diameter
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2401/00Physical properties
    • D10B2401/13Physical properties anti-allergenic or anti-bacterial

Definitions

  • the present invention relates to a filter medium, and more particularly, to an antiviral filter medium.
  • Microbial and viral pathogens are a growing public health problem.
  • novel viruses such as swine influenza and avian influenza is at risk.
  • some viruses are highly contagious and/or have a high mortality rate, not only patients exposed to the virus but also healthcare workers who treat patients are exposed to a significantly high risk of infection.
  • microorganisms or viruses such as bacteria
  • the spread of microorganisms or viruses, such as bacteria is when contaminants such as droplets discharged from an infected person who have them contaminate the surface or the air of an object, and the microorganism or virus is re-entered into the human body through the body or clothing that has come into contact with the surface of the contaminated object. It may be achieved through transmission or by direct transmission of microorganisms or viruses through breathing in contaminated air.
  • air conditioners such as centralized air conditioners provided in vehicles such as buses and private cars, subways, trains, etc., and air purifiers arranged in various public buildings, etc.
  • vehicle such as buses and private cars, subways, trains, etc.
  • air purifiers arranged in various public buildings, etc.
  • the lack of a function to filter or kill pathogenic microorganisms such as various bacteria and viruses contained therein is a threat to public health, such as fear of group infection.
  • an object of the present invention is to provide an antiviral filter medium that can solve the concern of virus infection caused by the filtered air.
  • the present invention provides an antiviral filter medium that can be widely used in filters for various air-conditioning devices as it has an excellent air filtration function while exhibiting anti-viral properties, and prevents deterioration of air filtration performance even when the use time is extended for a long time. It serves a different purpose to provide.
  • the present invention provides an antiviral filter medium including a first member formed of fibers having an antiviral component including a surfactant.
  • the surfactant may be provided to be exposed on the fiber surface.
  • the antiviral component is provided on the fiber by immersing the first member in a coating solution containing the antiviral component, or the antiviral component is provided in the electrospinning solution for forming the first member and may be provided on the fiber.
  • the average diameter of the fibers forming the first member may be 0.05 to 1 ⁇ m
  • the basis weight may be 2 g/m 2 or less
  • the average pore diameter may be 3 ⁇ m or less.
  • the surfactant may include any one or more of a cationic surfactant and an anionic surfactant.
  • the antiviral component is provided on the fiber by immersing the first member in a coating solution containing the antiviral component, and the surfactant in the coating solution may be provided at a concentration of 0.1 to 1% by weight. have.
  • the cationic surfactant may include cetyl trimethylammonium bromide, and the anionic surfactant may include sodium lauryl sulfate.
  • it may further include a porous second member disposed on one side of the first member and performing a supporting function.
  • the second member may include a heat-sealable fiber having a diameter of 30 to 50 ⁇ m, and a basis weight of 30 to 100 g/m 2 .
  • the heat-sealable fiber may be a core sheath-type composite fiber formed of a sheath including polyethylene and a core including polypropylene having a higher melting point than the sheath.
  • it may further include any one or more of a porous third member that is a woven, knitted, nonwoven, or mesh sheet formed of silver-containing fibers and a fourth member that is electrostatically treated melt blown nonwoven fabric.
  • the third member is formed through a ply-twisted yarn including a silver wire
  • the ply-twisted yarn is formed from a core, a first covering yarn including a silver line surrounding the core, and the outside of the first covering yarn surrounding the core. It may include a second covering yarn surrounding.
  • the fourth member may include polypropylene fibers having a diameter of 1 to 10 ⁇ m, and a basis weight of 15 to 50 g/m 2 .
  • a porous second member performing a supporting function is further provided on one side of the first member, and the third member and the fourth member may be disposed in the order of the other side opposite to one side of the first member.
  • the present invention provides an air filter unit including the antiviral filter media according to the present invention bent so that mountains and valleys are alternately formed in one direction, and a filter frame surrounding the antiviral filter media.
  • the present invention provides an air conditioner comprising the antiviral filter medium according to the present invention.
  • the anti-viral filter media according to the present invention has very good air filtration efficiency through the breathability given while retaining the anti-viral performance, and furthermore, the deterioration of the air filtration performance is prevented or minimized even when the use time is extended for a long time. Therefore, it is very suitable as a filter medium for various types of air conditioners and masks. In addition, it can be used as fabrics for bedding, protective clothing, and medical clothes, as it is difficult for hospital microorganisms such as viruses to survive in the filter media.
  • FIG. 1 is a cross-sectional schematic view of an antiviral filter medium according to an embodiment of the present invention
  • FIG. 3a to 3c are SEM photos of the surface of the first member included in the antiviral filter media according to an embodiment of the present invention
  • Figure 3a is a SEM photo of the surface of the first member electrospun with PVDF
  • Figure 3b is PTFE
  • FIG. 3C is a surface SEM photograph of the first member electrospun with polyether sulfone
  • 5a is a schematic diagram showing an SEM photograph of a first member formed of nanofibers included in an antiviral filter medium according to an embodiment of the present invention and a pore diameter thereof;
  • Figure 5b is a schematic view showing the SEM photograph and these pore diameters of the first member formed of microfibers in contrast to Figure 5a;
  • FIG. 6 is a schematic view showing the dust filtration mechanism of the electrostatically treated melt blown nonwoven fabric as a fourth member included in the antiviral filter media according to an embodiment of the present invention, and the electrostatically treated melt blown nonwoven fabric collected on the fiber surface. SEM picture showing dust,
  • FIG. 7 is a graph showing a decrease in filtration efficiency according to usage time when an electrostatically treated melt blown nonwoven fabric is used alone as a fourth member included in the antiviral filter medium according to an embodiment of the present invention
  • MB 8 is an antiviral filter medium (fourth member (MB) + first member (PVDF nanoweb) + second member (CCL70)) according to an embodiment of the present invention and a filter medium according to a comparative example (fourth member) (MB) + second member (CCL70)) graph comparing the change in filtration efficiency with time,
  • 10 and 11 are a perspective view and a cross-sectional schematic view of an air filter unit according to an embodiment of the present invention.
  • the antiviral filter media 100 includes a porous first member 20 having antiviral properties, and a porous second member having a supporting function. (10), it may further include a porous third member 30 having antibacterial properties and a porous fourth member 40 electrostatically treated.
  • the first member 20 having an antiviral property is formed of fibers having an antiviral component, and has a porous structure.
  • the first member 20 may be a fibrous web formed of fibers having an antiviral component, and more specifically, may have a three-dimensional network structure formed of fibers.
  • the fiber 1 having the anti-viral component includes a known fiber-forming component 2 capable of forming fibers in addition to the anti-viral component 3, and preferably, the fiber-forming component 2 is formed on the fiber. It may be a known component that can be implemented in a shape, preferably a component capable of electrospinning.
  • the fiber-forming component (2) may include at least one component selected from the group consisting of a fluorine-based compound, polyacrylonitrile (PAN), polyurethane, polyester, polyamide, and polyethersulfone (PES).
  • the fluorine-based compound is, for example, polytetrafluoroethylene (PTFE)-based, tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA)-based, tetrafluoroethylene-hexafluoropropylene copolymer (FEP)-based, Tetrafluoroethylene-hexafluoropropylene-perfluoroalkyl vinyl ether copolymer (EPE), tetrafluoroethylene-ethylene copolymer (ETFE), polychlorotrifluoroethylene (PCTFE), chlorotrifluoro It may include any one or more selected from the group consisting of roethylene-ethylene copolymer (ECTFE)-based and polyvinylidene fluoride (PVDF)-based.
  • ECTFE roethylene-ethylene copolymer
  • PVDF polyvinylidene fluoride
  • the fiber-forming component may include polyvinylidene fluoride (PVDF) in terms of low manufacturing cost, easy mass production of nanofibers through electrospinning, and excellent mechanical strength and chemical resistance.
  • PVDF polyvinylidene fluoride
  • PAN polyacrylonitrile
  • the fiber-forming component having excellent wettability in a coating solution containing an antiviral component to be described later, and the adhesion between the surface of the fiber-forming component and the antiviral component.
  • the use of polyacrylonitrile fiber-forming ingredients can kill viruses more efficiently. there is an advantage
  • the antiviral component (3) can be used without limitation if it is a known viral component, but it essentially includes a surfactant, and specifically, various functional groups included in the surfactant combine with the virus to improve the antiviral performance.
  • Surfactants capable of expressing may be used.
  • the surfactant may be a cationic surfactant and/or an anionic surfactant.
  • anionic surfactant a known anionic surfactant may be used, but for example, a C8 to C22 alkyl sulfonate salt such as sodium lauryl sulfate, and/or alpha sulfo such as a linear alkyl benzene sulfonic acid Nated carboxylic acids or esters thereof and the like can be used.
  • the cationic surfactant may be used without limitation in the case of a known cationic surfactant, for example, cetyl trimethylammonium bromide may be used.
  • the surfactant may be selected to improve the hydrophilicity of the first member 20 in addition to the function of expressing the antiviral performance, and in this case, it may be more useful when the material of the first member has hydrophobicity.
  • the antiviral component (3) containing the surfactant is preferably provided so as to be exposed to the surface of the fiber-forming component (2) of the fiber (1) as shown in Figure 1, specifically, the surface of the fiber (1) It may be provided to cover part or all of it, and through this, the degree of improvement in antiviral performance or hydrophilicity can be further improved.
  • the antiviral component (3) containing the surfactant is dipping the first member (20) in a coating solution containing the antiviral component (3) so that the antiviral component (3) is on the fiber (1) Or it may be provided on the fiber (1) by mixing the antiviral component (3) with the electrospinning solution for forming the first member (20) and then electrospinning it.
  • the fiber 1 may have an average diameter of 0.05 to 1 ⁇ m, in another example 0.1 to 0.4 ⁇ m.
  • the basis weight of the first member 20 may be 2 g/m 2 or less, in another example 1 g/m 2 or less.
  • the average pore diameter may be 3 ⁇ m or less, in another example, 0.5 to 2 ⁇ m, which may be more advantageous to achieve the object of the present invention.
  • the coating solution contains the surfactant in the coating solution at a concentration of 0.1 to 1% by weight, more preferably may be contained in a concentration of 0.1 to 0.6% by weight. If the concentration is less than 0.1% by weight, the expression of antiviral properties may be weak. In addition, if the concentration exceeds 1% by weight, it is possible to reduce the air permeability of the first member.
  • the antiviral filter media may be processed in a bent form a number of times as shown in FIG. 10 , and there is a fear that antiviral properties may be deteriorated due to large detachment of the antiviral component 3 during the processing process.
  • the coating solution may further include a solvent in addition to the antiviral component.
  • the solvent may be a known solvent capable of dispersing or dissolving the antiviral component without physically or chemically invading the fiber-forming component.
  • the solvent may be, for example, water and/or an organic solvent.
  • the first member 20 described above may further include a porous second member 10 performing a supporting function on one surface.
  • the second member 10 is not particularly limited if it is a porous member that normally serves as a support, but may preferably be a woven fabric, a knitted fabric or a non-woven fabric in its shape.
  • a nonwoven fabric a known nonwoven fabric such as a chemical bonding nonwoven fabric, a thermal bonding nonwoven fabric, a dry nonwoven fabric such as an airlay nonwoven fabric, a wet nonwoven fabric, a spanless nonwoven fabric, a needle punching nonwoven fabric, or a melt blown nonwoven fabric may be used, for example, the second member (10) may be a thermal bonding nonwoven fabric.
  • the pore diameter, porosity, basis weight, etc. of the second member 10 may vary in consideration of the desired strength, filtration efficiency, etc., so the present invention is not particularly limited thereto.
  • a nonwoven fabric having a diameter of 30 to 50 ⁇ m and a basis weight of 30 to 150 g/m 2 and an average pore diameter of 30 to 100 ⁇ m may be used.
  • the second member 10 is not limited in its material. As a non-limiting example, it may include a synthetic fiber preferably selected from the group consisting of polyester, polypropylene, nylon and polyethylene. However, the second member 10 may include heat-sealable fibers to enable attachment to the first member 20 without a separate adhesive.
  • the heat-sealable fiber may be a low-melting-point polyester or low-melting polyolefin-based material, and may preferably include a low-melting polyolefin-based component, and more specifically, a sheath comprising polyethylene and a poly(polyethylene) having a higher melting point than the sheath. It may be a core-sheath type composite fiber formed with a core including propylene.
  • the first member 20 may include fibers 1 having a diameter of 1 ⁇ m or less. When joined, it exhibits superior bonding properties compared to the case of using the second member formed of polyester fibers, and has excellent flexibility compared to the second member formed of polyester fibers with strong brittle characteristics. It can better respond to the external force applied while passing through, and thus it can be advantageous to prevent separation at the junction interface.
  • the antiviral filter media 100 may further include a third member 30 that exhibits antibacterial properties.
  • the third member 30 may be used without limitation in the case of a porous member containing a known component exhibiting antibacterial properties.
  • the third member 30 may include silver-containing fibers exhibiting antibacterial properties.
  • the silver-containing fiber is a silver wire made of silver alone, a metal wire containing other metals such as copper in addition to silver, or a silver wire and/or a silver-containing metal wire braided with a conventional non-metal fiber.
  • a metal wire containing other metals such as copper
  • it may be linearly formed by mixing a metal other than silver in a non-solid state with silver, that is, in a non-solid state, ie, silver and non-alloy state.
  • the silver and the other metal may be arranged such that silver and other metal occupy a predetermined area regularly or irregularly in a single linear region, For example, it may have a double structure in which a layer is formed by enclosing silver on the outside of the copper wire.
  • the copper wire may impart excellent flexibility to the silver wire, and the surrounding silver may have an average thickness of 3 to 3200 nm, and preferably, an average thickness of 5 to 3000 nm. If the average thickness of the surrounding silver is less than 3 nm, it is easy to manufacture so that copper, which is the central metal, is exposed to the outside, so that the antibacterial function may be lowered.
  • the double structure of the silver wire is a step of drawing a copper material to a predetermined diameter, integrating the copper material drawn by a cladding process and a silver plate to form a double structure in which the silver plate surrounds the outside of the copper material. It may be formed including the steps of obtaining a wire and obtaining a silver wire through wire drawing of the double-structured wire.
  • the silver wire may be obtained by processing a solution containing a liquid Ag powder solution on the drawn copper material to coat Ag with a uniform thickness on the surface of the copper material, and then performing wire drawing to obtain the silver wire.
  • silver wire may be obtained by plating silver on the drawn copper material and subjecting it to wire drawing.
  • the silver wire and the conventional fiber are a known manufacturing method in the field of textiles in which two kinds of fibers are braided, and the known two kinds of fibers. It may be a ply-twisted yarn implemented by appropriately adopting an arrangement structure.
  • the silver wire used may be a wire made of only silver or a metal wire containing silver and other metals.
  • the ply-twisted yarn is a yarn having a triple structural cross section including a core yarn, a first covering yarn including a silver line surrounding the core, and a second covering yarn surrounding the outside of the first covering yarn surrounding the core yarn can
  • the core and second covering yarns may be used without limitation as long as they are fibers that can be used to improve the flexibility and elasticity of the ply-twisted yarn, and preferably, any one or more selected from natural fibers and synthetic fibers may be used, and more preferably poly Ester-based fibers may be used.
  • the core yarn and the second covering yarn may be formed of a mono yarn or a plurality of filament yarns, and preferably a fiber formed of a plurality of filament yarns.
  • the screening and second covering yarns may be used without limitation as long as they are fibers of fineness commonly used in the art, and preferably each independently may have a fineness of 20 to 100De' (denier), more preferably The fineness may be 30 ⁇ 75De'. If the fineness of the screening and the second covering yarn is independently less than 20De', the antibacterial performance and durability according to the single yarn of the silver wire may be reduced. and, thereby, there is a risk of interfacial separation.
  • the second covering yarn may be twisted at a twist number of 350 to 1100 TPM, preferably twisted at 450 to 1000 TPM, and may be included in the ply-twisted yarn. If the number of twists of the second covering yarn is less than 350 TPM, the durability and antibacterial performance according to the single yarn of the silver wire may be deteriorated. In addition, when the number of twists exceeds 1100 TPM, elasticity and flexibility may be reduced, and as the area of the silver wire exposed to the surface decreases, the antibacterial performance may be relatively reduced.
  • the third member 30 is a member implemented to have a porous structure including the above-mentioned silver wire made of silver, silver-containing metal wire and/or ply-twisted yarn, and specific examples thereof include fabric, knitted fabric, nonwoven fabric Or it may be a mesh sheet.
  • the woven fabric, knitted fabric, nonwoven fabric or mesh sheet may further include natural fiber and/or synthetic fiber that does not contain a silver wire.
  • the fourth member 40 may be disposed on one side of the above-described first member 20 to perform a function of protecting the first member 20 .
  • a function of protecting one side of the third member 30 may be performed.
  • the fourth member 40 may be a member through which external air to be filtered first passes, and thus may perform a function of improving filtration performance for fine particles in the air.
  • the fourth member 40 may be a porous member performing a function of filtering fine dust, dust, etc. contained in the air using electrostatic force.
  • the fourth member 40 may be, for example, a known nonwoven fabric, and preferably may be an electrostatically treated melt blown nonwoven fabric. The electrostatic treatment can be performed on the entire porous member, but it is revealed that only a part of it can be treated, and a detailed description thereof will be omitted because a known method used in the manufacture of a conventional electrostatic treatment filter can be appropriately employed. do.
  • the diameter and basis weight of the fibers contained in the fourth member 40 can be appropriately adjusted according to the purpose.
  • the fourth member 40 has a diameter of 1 to 10 ⁇ m.
  • Phosphorus fibers are included, and the basis weight may be 15 to 50 g/m 2 , and in another example, the basis weight may be 20 to 35 g/m 2 .
  • the average pore diameter may be less than 20 ⁇ m, another example may be 10 ⁇ m. If the average pore diameter of the fourth member 40 is excessively small, air permeability may decrease and pressure loss may increase, and if the average pore diameter is excessively large, filtration efficiency may decrease.
  • the average diameter of the fibers forming the fourth member 40 when the average diameter of the fibers forming the fourth member 40 is excessively small, air permeability may be reduced, pressure loss may increase, and if the average diameter of the fibers is excessively large, filtration efficiency may be reduced. In addition, if the basis weight of the fourth member 40 is excessively low, the filtration efficiency may be reduced as the deviation increases, or uniform filtration efficiency may not be expressed.
  • the fibers forming the fourth member 40 may include a synthetic polymer component selected from the group consisting of polyester, polyurethane, polyolefin, and polyamide; Or it may include a natural polymer component including a cellulose-based, for example, may include polypropylene.
  • the antiviral filter medium in which the fourth member 40 and the first member 20 are combined it exhibits a synergistic action in terms of durability of filtration performance together with the first member 20 .
  • the above-described first member 20 may have a three-dimensional network structure by accumulating fibers of 1 ⁇ m or less.
  • the first member 20 may be designed to have a pore size capable of physically filtering fine dust of PM2.5 or less, and a flow path may be formed to prevent a decrease in the flow rate of air passing therethrough.
  • the first member 20 may function to compensate for the problem of a reduction in collection efficiency due to static electricity that may occur in the electrostatically treated fourth member 40 and to maintain the initially designed filtration efficiency for a long time.
  • the electrostatically treated fourth member 40 adsorbs dust to the fiber surface using electrostatic force, and as time elapses, the electrostatic force decreases. It is lowered to less than 50% of the initially designed efficiency, but there is a problem that the replacement cycle is very short.
  • the collection efficiency continues to decrease, whereas the collection efficiency decreases.
  • the above-described anti-viral filter media 100 may be bent to have a plurality of mountains and valleys alternately arranged in one direction as shown in FIGS. 10 and 11 to implement the air filter unit 200 .
  • the air filter unit 200 is arranged to surround at least one side, preferably four sides, of the bent antiviral filter medium 210 to support the antiviral filter medium 210 and change the shape of the air filter unit. It may further include a filter frame 220 for maintaining.
  • the antiviral filter media 100 or the air filter unit 200 described above may be used to replace the air filter provided in various known air conditioners.
  • the air conditioner may be a vehicle such as a bus or private vehicle, a transportation means such as a subway or a train, an air conditioner provided in various public buildings, or an air purifier disposed in various indoor spaces, and the air conditioner has an antiviral function
  • the filter media it is possible to filter or kill pathogenic microorganisms such as various bacteria or viruses included in the air introduced from the outside or circulated in the room.
  • PAN Polyacrylonitrile
  • the second member which is a nonwoven fabric (Namyang Nonwoven Co., Ltd., CCP30) formed of a core-sheath composite fiber having a thickness of about 20 ⁇ m and a melting point of about 120°C as a sheath and polypropylene as a core.
  • CCP30 Nonwoven Co., Ltd., CCP30
  • a filter media was prepared.
  • the PAN nanofiber web had an average diameter of fibers of 0.2 ⁇ m, a basis weight of 20 g/m 2 , and an average pore diameter of 1 ⁇ m.
  • an antiviral coating solution which is an aqueous solution in which an anionic surfactant, sodium lauryl sulfate, is dissolved at a concentration of 0.1% by weight, take it out and pass it through calendering to remove the excess coating solution and then at a temperature of 70°C. and dried to prepare antiviral filter media as shown in Table 1 below.
  • the specimen was prepared to be 4 cm wide and 4 cm long. After that, 200 ⁇ l of PED virus (coronaviridae, Enveloped RNA virus) was treated on each specimen, and after standing at 23° C. for 14 hours, 1X DMEM (0.3% Tryptose Phosphate Broth, 0.02% Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin), 800 ⁇ l of an inoculation medium was added to recover the virus located on the specimen.
  • PED virus coronaviridae, Enveloped RNA virus
  • the virus titer had a TCID value of 5.0000, and the positive control group was evaluated by treating only the virus stock solution at 200 ⁇ l 23° C. for 14 hours and then treating the inoculation medium in the same way, and the TCID value was 5.0000.
  • the specimen was prepared to be 4 cm wide and 4 cm long. After the prepared specimen was placed on a 1.5ml tube, 200 ⁇ l of each PED virus was treated on the specimen and centrifuged at 23°C. After centrifugation, 800 ⁇ l of inoculation medium containing 1X DMEM (0.3% Tryptose Phosphate Broth, 0.02% Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin) was added to the virus obtained by centrifugation, followed by decimal dilution and antiviral performance In the same manner as in evaluation A, the CPE of the cells was checked and the TCID value was calculated, and the results are shown in Table 1 below. The virus titer used at this time had a TCID value of 5.0000.
  • the air permeability was measured under the same conditions by installing a filter medium in an air permeability tester (TEXTEST). With respect to the measured results, the air permeability of the other examples was expressed as a relative percentage based on the air permeability of Comparative Example 1 as 100%. The closer the percentage is to 0, the greater the fluctuation in air permeability.
  • Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative Example 1 Surfactant (type/concentration (wt%) A/0.1 B/0.1 A/0.3 + B/0.3 A/0.08 A/0.98 A/1.2 unprocessed Antiviral performanceATCID50 (log 10 ) 0.563 0.581 0.896 1.551 0.432 0.425 4.990 Antiviral performanceBTCID50 (log 10 ) 3.500 3.558 4.000 4.840 3.225 3.220 5.000 air permeability 95.6 95.5 90.3 98.5 85.0 53.3 100
  • A is an anionic surfactant that is sodium lauryl sulfate
  • B is a cationic surfactant that is cetyl trimethylamonium bromide.
  • antiviral performance A As a result of antiviral performance A, it can be confirmed that Examples 1, 2, 4, and 5 have virus removal performance of 99.0% or more.
  • antiviral performance B As a result of antiviral performance B, it can be seen that Examples 1, 2, 4, and 5 had a virus removal performance of 90.0% or more.
  • Example 6 in which the concentration of the surfactant is excessive, it can be seen that the air permeability is severely inhibited.

Abstract

Provided is an antiviral filter medium. The antiviral filter medium according to an embodiment of the present invention is implemented by including a first member formed of fibers having an antiviral component including a surfactant. Accordingly, the antiviral filter medium has very good air filtration efficiency through breathability provided with antiviral performance possessed, and furthermore, can be very suitable as filters in various kinds of air conditioners and media of various kinds of masks, because the deterioration of air filtration performance is prevented or minimized even when the use time is extended for a long time.

Description

항바이러스 필터여재, 이를 포함하는 에어필터 유닛 및 공조장치Antiviral filter media, air filter unit and air conditioner including same
본 발명은 필터여재에 관한 것이며, 보다 구체적으로는 항바이러스 필터여재에 대한 것이다.The present invention relates to a filter medium, and more particularly, to an antiviral filter medium.
미생물 및 바이러스 병원체는 증가하기 있는 공중 보건 문제이다. 현재, 돼지 인플루엔자나 조류 인플루엔자와 같은 신종 바이러스의 유행이 위험시 되고 있다. 특히, 일부 바이러스는 높은 전염성, 및/또는 높은 치사율을 갖기 때문에 바이러스에 노출된 환자뿐만 아니라 환자의 치료를 담당하는 의료 종사자들 역시 상당히 높은 감염위험에 노출되어 있다.Microbial and viral pathogens are a growing public health problem. Currently, the epidemic of novel viruses such as swine influenza and avian influenza is at risk. In particular, since some viruses are highly contagious and/or have a high mortality rate, not only patients exposed to the virus but also healthcare workers who treat patients are exposed to a significantly high risk of infection.
세균과 같은 미생물이나 바이러스의 전파는 이를 보유한 감염자로부터 배출된 비말 등의 오염물질이 물체의 표면이나 공기 중을 오염시키고, 오염된 물체의 표면에 접촉한 신체나 의복을 통해서 인체 내로 미생물이나 바이러스 다시 전달됨을 통해 이루어지거나 오염된 공기 중에서 호흡 등을 통해서 미생물이나 바이러스가 직접 전파되어 이루어질 수 있다. The spread of microorganisms or viruses, such as bacteria, is when contaminants such as droplets discharged from an infected person who have them contaminate the surface or the air of an object, and the microorganism or virus is re-entered into the human body through the body or clothing that has come into contact with the surface of the contaminated object. It may be achieved through transmission or by direct transmission of microorganisms or viruses through breathing in contaminated air.
특히 버스, 자가용 등의 차량이나 지하철, 기차 등의 운송수단이나, 각종 공공 건물 등에 구비되는 중앙식 공조장치나, 각종 실내에 배치되는 공기청정기 등의 공조장치는 외부에서 또는 실내에서 순환되는 공기 중에 포함된 각종 세균이나 바이러스 등의 병원미생물을 여과시키거나 사멸시킬 수 있는 기능이 부재해 집단 감염 우려가 있는 등 공공 보건이 더욱 위협받고 있는 실정이다. In particular, air conditioners such as centralized air conditioners provided in vehicles such as buses and private cars, subways, trains, etc., and air purifiers arranged in various public buildings, etc. The lack of a function to filter or kill pathogenic microorganisms such as various bacteria and viruses contained therein is a threat to public health, such as fear of group infection.
이에 따라서 공기 중의 바이러스 등의 병원미생물을 여과 및/또는 사멸시킬 수 있는 항바이러스 성능을 갖는 필터여재에 대한 요구가 매우 높은 상황이다.Accordingly, there is a very high demand for a filter medium having antiviral performance that can filter and/or kill pathogenic microorganisms such as viruses in the air.
본 발명은 상기와 같은 점을 감안하여 안출한 것으로, 우수한 항바이러스 성능을 가짐에 따라서 공기 중에 포함된 바이러스가 필터링 되는 과정에서 바이러스가 사멸되며, 여재가 바이러스에 오염되는 경우에도 여재 상에서 바이러스가 사멸됨에 따라서 여과된 공기로 인한 바이러스 감염 우려를 해소시킬 수 있는 항바이러스 필터여재를 제공하는데 목적이 있다. The present invention was devised in consideration of the above points, and as it has excellent antiviral performance, the virus is killed in the process of filtering the virus contained in the air, and the virus is killed on the filter medium even when the filter medium is contaminated with viruses Accordingly, an object of the present invention is to provide an antiviral filter medium that can solve the concern of virus infection caused by the filtered air.
또한, 본 발명은 항바이러스 특성을 발현하면서도 우수한 공기여과 기능을 가지며, 사용시간이 장시간 연장되는 경우에도 공기여과 성능의 저하가 방지됨에 따라서 각종 공조장치용 필터류에 널리 사용될 수 있는 항바이러스 필터여재를 제공하는데 다른 목적이 있다.In addition, the present invention provides an antiviral filter medium that can be widely used in filters for various air-conditioning devices as it has an excellent air filtration function while exhibiting anti-viral properties, and prevents deterioration of air filtration performance even when the use time is extended for a long time. It serves a different purpose to provide.
상술한 과제를 해결하기 위하여 본 발명은 계면활성제를 포함하는 항바이러스 성분을 구비한 섬유들로 형성된 제1부재를 포함하는 항바이러스 필터여재를 제공한다.In order to solve the above problems, the present invention provides an antiviral filter medium including a first member formed of fibers having an antiviral component including a surfactant.
본 발명의 일 실시예에 의하면, 상기 계면활성제는 섬유 표면 상에 노출되도록 구비될 수 있다. According to an embodiment of the present invention, the surfactant may be provided to be exposed on the fiber surface.
또한, 상기 항바이러스 성분은 항바이러스 성분을 포함하는 코팅용액에 제1부재를 침지시켜서 항바이러스 성분이 섬유 상에 구비되거나, 또는 상기 제1부재를 형성하기 위한 전기방사용액에 항바이러스 성분이 구비되어 섬유 상에 구비될 수 있다. In addition, the antiviral component is provided on the fiber by immersing the first member in a coating solution containing the antiviral component, or the antiviral component is provided in the electrospinning solution for forming the first member and may be provided on the fiber.
또한, 상기 제1부재를 형성하는 섬유의 평균직경은 0.05 ~ 1㎛이고, 평량은 2g/㎡ 이하, 평균공경은 3㎛ 이하일 수 있다. In addition, the average diameter of the fibers forming the first member may be 0.05 to 1 μm, the basis weight may be 2 g/m 2 or less, and the average pore diameter may be 3 μm or less.
또한, 상기 계면활성제는 양이온성 계면활성제 및 음이온성 계면활성제 중 어느 하나 이상을 포함할 수 있다. In addition, the surfactant may include any one or more of a cationic surfactant and an anionic surfactant.
또한, 상기 항바이러스 성분은 항바이러스 성분을 포함하는 코팅용액에 제1부재를 침지시켜서 항바이러스 성분이 섬유 상에 구비되며, 상기 코팅용액 내 상기 계면활성제는 0.1 ~ 1중량% 농도로 구비될 수 있다. In addition, the antiviral component is provided on the fiber by immersing the first member in a coating solution containing the antiviral component, and the surfactant in the coating solution may be provided at a concentration of 0.1 to 1% by weight. have.
또한, 상기 양이온성 계면활성제는 세틸 트리메틸아모늄 브로마이드(Cetyl trimethylammonium bromide)를 포함하고, 상기 음이온성 계면활성제는 소듐 라우릴설페이트(Sodium Lauryl Sulfate)를 포함할 수 있다. In addition, the cationic surfactant may include cetyl trimethylammonium bromide, and the anionic surfactant may include sodium lauryl sulfate.
또한, 상기 제1부재 일측에 배치되며, 지지기능을 수행하는 다공성의 제2부재를 더 포함할 수 있다. In addition, it may further include a porous second member disposed on one side of the first member and performing a supporting function.
또한, 상기 제2부재는 직경이 30 ~ 50㎛인 열융착성 섬유를 포함하며, 평량이 30 ~ 100g/㎡일 수 있다.In addition, the second member may include a heat-sealable fiber having a diameter of 30 to 50 μm, and a basis weight of 30 to 100 g/m 2 .
또한, 상기 열융착성 섬유는 폴리에틸렌을 구비하는 초부 및 상기 초부 보다 융점이 높은 폴리프로필렌을 구비하는 심부로 형성된 심초형 복합섬유일 수 있다. In addition, the heat-sealable fiber may be a core sheath-type composite fiber formed of a sheath including polyethylene and a core including polypropylene having a higher melting point than the sheath.
또한, 은을 함유하는 섬유로 형성된 직물, 편물, 부직포 또는 메쉬 시트인 다공성의 제3부재 및 정전처리된 멜트블로운 부직포인 제4부재 중 어느 하나 이상을 더 포함할 수 있다. In addition, it may further include any one or more of a porous third member that is a woven, knitted, nonwoven, or mesh sheet formed of silver-containing fibers and a fourth member that is electrostatically treated melt blown nonwoven fabric.
또한, 상기 제3부재는 은 선을 포함하는 합연사를 통해 형성되며, 상기 합연사는 심사, 상기 심사를 둘러싸는 은 선을 포함하는 제1커버링사, 및 상기 심사를 둘러싼 제1커버링사 외부를 둘러싸는 제2커버링사를 포함할 수 있다. In addition, the third member is formed through a ply-twisted yarn including a silver wire, and the ply-twisted yarn is formed from a core, a first covering yarn including a silver line surrounding the core, and the outside of the first covering yarn surrounding the core. It may include a second covering yarn surrounding.
또한, 상기 제4부재는 직경이 1 ~ 10㎛인 폴리프로필렌 섬유를 포함하며, 평량이 15 ~ 50g/㎡일 수 있다. In addition, the fourth member may include polypropylene fibers having a diameter of 1 to 10 μm, and a basis weight of 15 to 50 g/m 2 .
또한, 지지기능을 수행하는 다공성의 제2부재가 제1부재 일측에 더 구비되며, 상기 제1부재 일측에 대향하는 타측에 제3부재 및 제4부재 순서로 배치될 수 있다. In addition, a porous second member performing a supporting function is further provided on one side of the first member, and the third member and the fourth member may be disposed in the order of the other side opposite to one side of the first member.
또한, 본 발명은 일 방향으로 산과 골이 교호적으로 형성되도록 절곡된 본 발명에 따른 항바이러스 필터여재 및 상기 항바이러스 필터여재를 둘러싸는 필터프레임을 포함하는 에어필터 유닛을 제공한다.In addition, the present invention provides an air filter unit including the antiviral filter media according to the present invention bent so that mountains and valleys are alternately formed in one direction, and a filter frame surrounding the antiviral filter media.
또한, 본 발명은 본 발명에 따른 항바이러스 필터여재를 포함하는 공조장치를 제공한다.In addition, the present invention provides an air conditioner comprising the antiviral filter medium according to the present invention.
본 발명에 의한 항바이러스 필터여재는 항바이러스 성능을 보유함과 더불어 부여된 통기성을 통해서 매우 우수한 공기 여과효율을 가지며, 이에 나아가 사용시간이 장시간 연장되는 경우에도 공기여과 성능의 저하가 방지 또는 최소화 됨에 따라서 각종 공조장치의 필터류, 각종 마스크류의 여재로써 매우 적합하다. 더불어 필터여재 내 바이러스 등의 병원미생물의 생존이 어려움에 따라서 침구나 방호복, 의료용 의복 등의 원단으로 활용될 수도 있다.The anti-viral filter media according to the present invention has very good air filtration efficiency through the breathability given while retaining the anti-viral performance, and furthermore, the deterioration of the air filtration performance is prevented or minimized even when the use time is extended for a long time. Therefore, it is very suitable as a filter medium for various types of air conditioners and masks. In addition, it can be used as fabrics for bedding, protective clothing, and medical clothes, as it is difficult for hospital microorganisms such as viruses to survive in the filter media.
도 1은 본 발명의 일 실시예에 의한 항바이러스 필터여재의 단면모식도, 1 is a cross-sectional schematic view of an antiviral filter medium according to an embodiment of the present invention;
도 2는 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 제1부재의 표면 SEM 사진, 2 is a SEM photograph of the surface of the first member included in the antiviral filter medium according to an embodiment of the present invention;
도 3a 내지 도 3c는 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 제1부재의 표면 SEM 사진으로, 도 3a는 PVDF로 전기방사된 제1부재의 표면 SEM 사진, 도 3b는 PTFE로 전기방사된 제1부재의 표면 SEM 사진, 그리고 도 3c는 폴리이더 술폰으로 전기방사된 제1부재 표면 SEM 사진,3a to 3c are SEM photos of the surface of the first member included in the antiviral filter media according to an embodiment of the present invention, Figure 3a is a SEM photo of the surface of the first member electrospun with PVDF, Figure 3b is PTFE A surface SEM photograph of the first member electrospun with, and FIG. 3C is a surface SEM photograph of the first member electrospun with polyether sulfone
도 4는 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 멜트블로운 제4부재의 표면 SEM 사진,4 is a surface SEM photograph of the fourth member of the melt blown contained in the antiviral filter medium according to an embodiment of the present invention;
도 5a는 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 나노섬유로 형성된 제1부재에 대한 SEM 사진 및 이의 공경을 나타낸 모식도,5a is a schematic diagram showing an SEM photograph of a first member formed of nanofibers included in an antiviral filter medium according to an embodiment of the present invention and a pore diameter thereof;
도 5b는 도 5a에 대비되는 마이크로 섬유로 형성된 제1부재의 SEM 사진 및 이들 공경을 나타낸 모식도,Figure 5b is a schematic view showing the SEM photograph and these pore diameters of the first member formed of microfibers in contrast to Figure 5a;
도 6은 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 제4부재로써 정전처리된 멜트블로운 부직포의 분진 여과 메커니즘을 나타낸 모식도 및 정전처리된 멜트블로운 부직포 내 섬유표면에 포집된 분진을 나타낸 SEM 사진, 6 is a schematic view showing the dust filtration mechanism of the electrostatically treated melt blown nonwoven fabric as a fourth member included in the antiviral filter media according to an embodiment of the present invention, and the electrostatically treated melt blown nonwoven fabric collected on the fiber surface. SEM picture showing dust,
도 7은 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 제4부재로써 정전처리된 멜트블로운 부직포의 단독 사용시, 사용시간에 따른 여과효율 감소를 나타낸 그래프,7 is a graph showing a decrease in filtration efficiency according to usage time when an electrostatically treated melt blown nonwoven fabric is used alone as a fourth member included in the antiviral filter medium according to an embodiment of the present invention;
도 8은 본 발명의 일 실시예에 의한 항바이러스 필터여재(제4부재(MB)+제1부재(PVDF나노웹)+제2부재(CCL70))와 비교예에 의한 필터여재(제4부재(MB)+제2부재(CCL70)) 간 시간에 따른 여과효율 변화를 대비한 그래프,8 is an antiviral filter medium (fourth member (MB) + first member (PVDF nanoweb) + second member (CCL70)) according to an embodiment of the present invention and a filter medium according to a comparative example (fourth member) (MB) + second member (CCL70)) graph comparing the change in filtration efficiency with time,
도 9는 본 발명의 일 실시예에 의한 항바이러스 필터여재에 포함되는 제4부재에 포집된 오염물에 대한 SEM 사진, 그리고9 is an SEM photograph of the contaminants collected on the fourth member included in the antiviral filter medium according to an embodiment of the present invention, and
도 10 및 도 11은 본 발명의 일 실시예에 의한 에어필터 유닛의 사시도와 단면모식도이다.10 and 11 are a perspective view and a cross-sectional schematic view of an air filter unit according to an embodiment of the present invention.
이하, 첨부한 도면을 참고로 하여 본 발명의 실시예에 대하여 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다. Hereinafter, with reference to the accompanying drawings, the embodiments of the present invention will be described in detail so that those of ordinary skill in the art to which the present invention pertains can easily implement them. The present invention may be embodied in many different forms and is not limited to the embodiments described herein.
도 1을 참조하여 설명하면, 본 발명의 일 실시예에 의한 항바이러스 필터여재(100)는 항바이러스 특성을 갖는 다공성의 제1부재(20)를 포함하며, 지지기능을 갖는 다공성의 제2부재(10), 항균 특성을 갖는 다공성의 제3부재(30) 및 정전 처리된 다공성의 제4부재(40)를 더 포함할 수 있다. 1, the antiviral filter media 100 according to an embodiment of the present invention includes a porous first member 20 having antiviral properties, and a porous second member having a supporting function. (10), it may further include a porous third member 30 having antibacterial properties and a porous fourth member 40 electrostatically treated.
먼저, 항바이러스 특성을 갖는 제1부재(20)에 대해서 설명한다. 상기 제1부재(20)는 항바이러스 성분을 구비한 섬유들로 형성된 것으로서, 다공성의 구조를 갖는다. 일예로 상기 제1부재(20)는 항바이러스 성분을 구비한 섬유들로 형성된 섬유웹일 수 있으며, 보다 구체적으로 섬유들로 형성된 3차원 네트워크 구조를 가질 수 있다. First, the first member 20 having an antiviral property will be described. The first member 20 is formed of fibers having an antiviral component, and has a porous structure. For example, the first member 20 may be a fibrous web formed of fibers having an antiviral component, and more specifically, may have a three-dimensional network structure formed of fibers.
상기 항바이러스 성분을 구비한 섬유(1)는 항바이러스 성분(3) 이외에 섬유를 형성할 수 있는 공지된 섬유형성성분(2)을 포함하며, 바람직하게는 상기 섬유형성성분(2)은 섬유 상의 형상으로 구현될 수 있는 공지의 성분일 수 있으며, 바람직하게는 전기방사가 가능한 성분일 수 있다. 상기 섬유형성성분(2)은 불소계 화합물, 폴리아크릴로니트릴(PAN), 폴리우레탄, 폴리에스테르, 폴리아미드 및 폴리이더설폰(PES)으로 이루어진 군에서 선택된 1종 이상의 성분을 포함할 수 있다. 상기 불소계 화합물은 일예로 폴리테트라플루오로에틸렌(PTFE)계, 테트라플루오로에틸렌-퍼플루오로알킬 비닐 에테르 공중합체(PFA)계, 테트라플루오로에틸렌-헥사플루오로프로필렌 공중합체(FEP)계, 테트라플루오로에틸렌-헥사플루오로프로필렌-퍼플루오로알킬 비닐 에테르 공중합체(EPE)계, 테트라플루오로에틸렌-에틸렌 공중합체(ETFE)계, 폴리클로로트리플루오로에틸렌(PCTFE)계, 클로로트리플루오로에틸렌-에틸렌 공중합체(ECTFE)계 및 폴리비닐리덴플루오라이드(PVDF)계로 이루어진 군에서 선택된 어느 하나 이상을 포함할 수 있다. 바람직하게는 상기 섬유형성성분은 제조 단가가 낮고 전기방사를 통하여 나노섬유의 대량생산이 용이하며, 기계적 강도 및 내화학성이 우수한 측면에서 폴리비닐리덴플루오라이드(PVDF)를 포함할 수 있다. 또는 상기 섬유형성성분은 후술하는 항바이러스 성분을 포함하는 코팅용액에 젖음성이 우수하고, 섬유형성성분 표면과 항바이러스 성분과의 부착력 등을 고려해 폴리아크릴로니트릴(PAN)이 바람직하게 사용될 수 있다. 특히 타액 유래의 미세한 액체방울 내 함유된 바이러스가 필터여재를 통과할 때 액체방울과 섬유 표면과의 상호작용을 고려할 때 폴리아크릴로니트릴 섬유형성성분을 사용하는 경우 바이러스를 보다 우수한 효율로 사멸시킬 수 있는 이점이 있다. The fiber 1 having the anti-viral component includes a known fiber-forming component 2 capable of forming fibers in addition to the anti-viral component 3, and preferably, the fiber-forming component 2 is formed on the fiber. It may be a known component that can be implemented in a shape, preferably a component capable of electrospinning. The fiber-forming component (2) may include at least one component selected from the group consisting of a fluorine-based compound, polyacrylonitrile (PAN), polyurethane, polyester, polyamide, and polyethersulfone (PES). The fluorine-based compound is, for example, polytetrafluoroethylene (PTFE)-based, tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA)-based, tetrafluoroethylene-hexafluoropropylene copolymer (FEP)-based, Tetrafluoroethylene-hexafluoropropylene-perfluoroalkyl vinyl ether copolymer (EPE), tetrafluoroethylene-ethylene copolymer (ETFE), polychlorotrifluoroethylene (PCTFE), chlorotrifluoro It may include any one or more selected from the group consisting of roethylene-ethylene copolymer (ECTFE)-based and polyvinylidene fluoride (PVDF)-based. Preferably, the fiber-forming component may include polyvinylidene fluoride (PVDF) in terms of low manufacturing cost, easy mass production of nanofibers through electrospinning, and excellent mechanical strength and chemical resistance. Alternatively, polyacrylonitrile (PAN) may be preferably used in consideration of the fiber-forming component having excellent wettability in a coating solution containing an antiviral component to be described later, and the adhesion between the surface of the fiber-forming component and the antiviral component. In particular, considering the interaction between the droplets and the fiber surface when the virus contained in the microscopic droplets derived from saliva passes through the filter media, the use of polyacrylonitrile fiber-forming ingredients can kill viruses more efficiently. there is an advantage
또한, 상기 항바이러스 성분(3)은 공지된 바이러스 성분인 경우 제한 없이 사용할 수 있으나, 계면활성제를 필수적으로 포함하며, 구체적으로는 계면활성제에 포함된 각종 작용기 등이 바이러스와 결합하여 항바이러스 성능을 발현할 수 있는 계면활성제가 사용될 수 있다. 이에 대한 일예로 상기 계면활성제는 양이온성 계면활성제 및/또는 음이온성 계면활성제를 사용할 수 있다. 상기 음이온성 계면활성제는 공지된 음이온성 계면활성제를 사용할 수 있으나, 일 예로, 소듐 라우릴설페이트(Sodium Lauryl Sulfate) 등의 C8 내지 C22 알킬 설포네이트염, 및/또는 선형 알킬 벤젠 설폰산과 같은 알파 설포네이트화된 카르복실산 또는 이의 에스테르 등을 사용할 수 있다. 또한, 양이온성 계면활성제는 공지된 양이온성 계면활성제의 경우 제한없이 사용할 수 있으며, 일 예로 세틸 트리메틸아모늄 브로마이드(Cetyl trimethylammonium bromide)를 사용할 수 있다. 음이온성 계면활성제로써 소듐 라우릴설페이트(Sodium Lauryl Sulfate)나, 양이온성 계면활성제로써 세틸 트리메틸아모늄 브로마이드(Cetyl trimethylammonium bromide)의 경우 적은 농도로도 우수한 항바이러스 성능을 발현할 수 있으며, 적은 농도로 사용이 가능해 공기투과도를 저해하지 않는 이점이 있다. In addition, the antiviral component (3) can be used without limitation if it is a known viral component, but it essentially includes a surfactant, and specifically, various functional groups included in the surfactant combine with the virus to improve the antiviral performance. Surfactants capable of expressing may be used. As an example of this, the surfactant may be a cationic surfactant and/or an anionic surfactant. As the anionic surfactant, a known anionic surfactant may be used, but for example, a C8 to C22 alkyl sulfonate salt such as sodium lauryl sulfate, and/or alpha sulfo such as a linear alkyl benzene sulfonic acid Nated carboxylic acids or esters thereof and the like can be used. In addition, the cationic surfactant may be used without limitation in the case of a known cationic surfactant, for example, cetyl trimethylammonium bromide may be used. In the case of Sodium Lauryl Sulfate as an anionic surfactant or Cetyl trimethylammonium bromide as a cationic surfactant, excellent antiviral performance can be expressed even with a small concentration. It has the advantage of not impairing air permeability because it can be used.
한편, 상기 계면활성제는 항바이러스 성능을 발현하는 기능 이외에 제1부재(20)의 친수성을 향상시키도록 선택될 수 있고, 이 경우 제1부재의 재질이 소수성을 갖는 경우에 더욱 유용할 수 있다. On the other hand, the surfactant may be selected to improve the hydrophilicity of the first member 20 in addition to the function of expressing the antiviral performance, and in this case, it may be more useful when the material of the first member has hydrophobicity.
또한, 계면활성제를 포함하는 항바이러스 성분(3)은 도 1에 도시된 것과 같이 섬유(1)의 섬유형성성분(2) 표면에 노출되도록 구비되는 것이 좋고, 구체적으로 섬유(1)의 표면을 일부 또는 전부 피복하도록 구비될 수 있으며, 이를 통해 항바이러스 성능이나 친수성 향상 정도를 더욱 개선할 수 있다. In addition, the antiviral component (3) containing the surfactant is preferably provided so as to be exposed to the surface of the fiber-forming component (2) of the fiber (1) as shown in Figure 1, specifically, the surface of the fiber (1) It may be provided to cover part or all of it, and through this, the degree of improvement in antiviral performance or hydrophilicity can be further improved.
또한, 상기 계면활성제를 포함하는 항바이러스 성분(3)은, 항바이러스 성분(3)을 포함하는 코팅용액에 제1부재(20)를 디핑시켜서 항바이러스 성분(3)이 섬유(1) 상에 구비되거나 또는 제1부재(20)를 형성하기 위한 전기방사용액에 항바이러스 성분(3)을 혼합시킨 뒤 이를 전기방사 시킴으로써 섬유(1) 상에 구비될 수 있다. In addition, the antiviral component (3) containing the surfactant is dipping the first member (20) in a coating solution containing the antiviral component (3) so that the antiviral component (3) is on the fiber (1) Or it may be provided on the fiber (1) by mixing the antiviral component (3) with the electrospinning solution for forming the first member (20) and then electrospinning it.
또한, 상기 섬유(1)는 평균직경이 0.05 ~ 1㎛, 다른 일예로 0.1 ~0.4㎛일 수 있다. 또한, 제1부재(20)의 평량은 2g/㎡ 이하, 다른 일예로 1g/㎡ 이하 수 있다. 또한, 평균공경은 3㎛ 이하, 다른 일예로 0.5 ~ 2㎛일 수 있으며, 이를 통해서 본 발명의 목적을 달성하기에 보다 유리할 수 있다. In addition, the fiber 1 may have an average diameter of 0.05 to 1 μm, in another example 0.1 to 0.4 μm. In addition, the basis weight of the first member 20 may be 2 g/m 2 or less, in another example 1 g/m 2 or less. In addition, the average pore diameter may be 3 μm or less, in another example, 0.5 to 2 μm, which may be more advantageous to achieve the object of the present invention.
한편, 항바이러스 성분(3)이 코팅용액을 통해서 제1부재(20) 내 섬유(1) 상에 구비되는 경우 상기 코팅용액은 코팅용액 내 상기 계면활성제를 0.1 ~ 1중량% 농도, 보다 바람직하게는 0.1 ~ 0.6중량% 농도로 함유할 수 있다. 만일 0.1 중량% 보다 적은 농도로 함유 시 항바이러스 특성의 발현이 미약할 수 있다. 또한, 만일 1중량%를 초과하는 농도로 구비 시 제1부재의 공기투과도를 저하시킬 수 있다. 또한, 후술하는 것과 같이 항바이러스 필터여재는 도 10과 같이 다수 회 절곡된 형태로 가공될 수 있는데, 가공과정에서 항바이러스 성분(3)의 탈리가 커서 항바이러스 특성이 저하될 우려가 있다. On the other hand, when the antiviral component 3 is provided on the fiber 1 in the first member 20 through the coating solution, the coating solution contains the surfactant in the coating solution at a concentration of 0.1 to 1% by weight, more preferably may be contained in a concentration of 0.1 to 0.6% by weight. If the concentration is less than 0.1% by weight, the expression of antiviral properties may be weak. In addition, if the concentration exceeds 1% by weight, it is possible to reduce the air permeability of the first member. In addition, as will be described later, the antiviral filter media may be processed in a bent form a number of times as shown in FIG. 10 , and there is a fear that antiviral properties may be deteriorated due to large detachment of the antiviral component 3 during the processing process.
상기 코팅용액은 항바이러스 성분 이외에 용제를 더 포함할 수 있다. 상기 용제는 섬유형성성분을 물리, 화학적으로 침해시키지 않으면서도 항바이러스 성분을 분산 또는 용해시킬 수 있는 공지의 용제를 선택할 수 있다. 상기 용제는 일 예로 물 및/또는 유기용매일 수 있다. The coating solution may further include a solvent in addition to the antiviral component. The solvent may be a known solvent capable of dispersing or dissolving the antiviral component without physically or chemically invading the fiber-forming component. The solvent may be, for example, water and/or an organic solvent.
상술한 제1부재(20)는 일면에 지지기능을 수행하는 다공성의 제2부재(10)를 더 포함할 수 있다. The first member 20 described above may further include a porous second member 10 performing a supporting function on one surface.
상기 제2부재(10)는 통상적으로 지지체 역할을 수행하는 다공성 부재인 경우 특별한 제한은 없으나, 그 형상에 있어서는 바람직하게는 직물, 편물 또는 부직포일 수 있다. 일예로 부직포인 경우 케미컬본딩 부직포, 써멀본딩 부직포, 에어레이 부직포 등의 건식부직포나 습식부직포, 스판레스 부직포, 니들펀칭 부직포 또는 멜트블로운와 같은 공지된 부직포를 사용할 수 있으며, 일예로 상기 제2부재(10)는 서멀본딩 부직포일 수 있다. The second member 10 is not particularly limited if it is a porous member that normally serves as a support, but may preferably be a woven fabric, a knitted fabric or a non-woven fabric in its shape. For example, in the case of a nonwoven fabric, a known nonwoven fabric such as a chemical bonding nonwoven fabric, a thermal bonding nonwoven fabric, a dry nonwoven fabric such as an airlay nonwoven fabric, a wet nonwoven fabric, a spanless nonwoven fabric, a needle punching nonwoven fabric, or a melt blown nonwoven fabric may be used, for example, the second member (10) may be a thermal bonding nonwoven fabric.
또한, 상기 제2부재(10)의 공경, 기공율, 평량 등은 목적하는 강도, 여과효율 등을 고려해 달라질 수 있어서 본 발명은 이에 대해 특별히 한정하지 않는다. 다만, 본 발명의 목적을 보다 용이하게 달성하기 위하여 직경이 30 ~ 50㎛인 섬유를 포함하며, 평량이 30 ~ 150g/㎡이고, 평균공경이 30 ~ 100㎛인 부직포를 사용할 수 있다. In addition, the pore diameter, porosity, basis weight, etc. of the second member 10 may vary in consideration of the desired strength, filtration efficiency, etc., so the present invention is not particularly limited thereto. However, in order to more easily achieve the object of the present invention, a nonwoven fabric having a diameter of 30 to 50 μm and a basis weight of 30 to 150 g/m 2 and an average pore diameter of 30 to 100 μm may be used.
또한, 상기 제2부재(10)는 그 재질에 있어서도 제한은 없다. 이에 대한 비제한적인 예로써, 바람직하게는 폴리에스테르, 폴리프로필렌, 나일론 및 폴리에틸렌으로 이루어진 군에서 선택되는 합성섬유를 포함할 수 있다. 다만, 상기 제2부재(10)는 제1부재(20)와 별도의 접착제 없이도 부착이 가능하도록 열융착성 섬유를 포함할 수 있다. 상기 열융착성 섬유는 저융점 폴리에스테르 또는 저융점 폴리올레핀계일 수 있는데, 바람직하게는 저융점 폴리올리핀계 성분을 포함할 수 있고, 더욱 구체적으로는 폴리에틸렌을 구비하는 초부 및 상기 초부 보다 융점이 높은 폴리프로필렌을 구비하는 심부로 형성된 심초형 복합섬유일 수 있다. 제1부재(20)는 직경이 1㎛ 이하로 작은 섬유(1)들을 포함할 수 있는데, 제2부재(10)가 폴리올레핀계 섬유들로 형성될 경우 제1부재(1)와 열 융착을 통해 접합될 시 폴리에스테르계 섬유들로 형성된 제2부재를 사용하는 경우에 대비해 보다 우수한 접합특성을 발휘하며, 브리틀한 특성이 강한 폴리에스테르계 섬유들로 형성된 제2부재에 대비해 유연성이 우수해 공기가 통과하면서 가해지는 외력에 더욱 잘 대응할 수 있고, 이에 따라서 접합계면에서의 분리를 방지하기 유리할 수 있다. In addition, the second member 10 is not limited in its material. As a non-limiting example, it may include a synthetic fiber preferably selected from the group consisting of polyester, polypropylene, nylon and polyethylene. However, the second member 10 may include heat-sealable fibers to enable attachment to the first member 20 without a separate adhesive. The heat-sealable fiber may be a low-melting-point polyester or low-melting polyolefin-based material, and may preferably include a low-melting polyolefin-based component, and more specifically, a sheath comprising polyethylene and a poly(polyethylene) having a higher melting point than the sheath. It may be a core-sheath type composite fiber formed with a core including propylene. The first member 20 may include fibers 1 having a diameter of 1 μm or less. When joined, it exhibits superior bonding properties compared to the case of using the second member formed of polyester fibers, and has excellent flexibility compared to the second member formed of polyester fibers with strong brittle characteristics. It can better respond to the external force applied while passing through, and thus it can be advantageous to prevent separation at the junction interface.
또한, 항바이러스 필터여재(100)는 항균 특성을 발현하는 제3부재(30)를 더 포함할 수 있다. 상기 제3부재(30)는 항균 특성을 발휘하는 공지의 성분을 함유하는 다공성 부재의 경우 제한 없이 사용될 수 있다. 바람직하게는 상기 제3부재(30)는 항균 특성을 발현하는 은을 함유하는 섬유를 포함할 수 있다. In addition, the antiviral filter media 100 may further include a third member 30 that exhibits antibacterial properties. The third member 30 may be used without limitation in the case of a porous member containing a known component exhibiting antibacterial properties. Preferably, the third member 30 may include silver-containing fibers exhibiting antibacterial properties.
상기 은을 함유하는 섬유는 은 단독으로 이루어진 은 선이거나, 은 이외에 구리 등의 다른 금속이 함유된 금속선, 또는 은 선 및/또는 은을 함유한 금속선이 비금속의 통상적인 섬유와 합사되어 형성한 합연사일 수 있다. 상기 구리 등의 다른 금속이 함유된 금속선에 대해서 설명하면, 은 이외의 다른 금속이 은과 비고용 상태, 즉 은과 비합금 상태로 혼합되어 선형으로 형성된 것일 수 있다. 은 이외의 다른 금속이 은과 비고용 상태로 혼합된 경우에, 은과 다른 금속은 한 가닥 선형의 영역 내 은과 다른 금속이 소정의 영역을 규칙적 또는 불규칙적으로 각각 차지하도록 배치된 것일 수 있으며, 일 예로 구리 선의 외부에 은이 둘러싸서 층을 형성한 이중 구조일 수 있다. 이때, 구리 선은 은 선에 우수한 유연성을 부여할 수 있으며, 둘러싼 은의 평균두께는 3 ~ 3200㎚일 수 있고, 바람직하게는 평균 두께가 5 ~ 3000㎚일 수 있다. 만일 상기 둘러싼 은의 평균 두께가 3㎚ 미만이면 중심 금속인 구리가 외부로 노출되도록 제조되기 쉬어서 항균기능이 저하될 수 있고, 은 선에서 은이 탈리되어 항균기능이 더욱 저하되거나, 탈리된 은이 이를 사용하는 사람의 호흡기로 흡입되거나 피부에 잔류되는 우려가 있다. 또한, 둘러싼 은의 평균 두께가 3200㎚를 초과하면 은 선의 유연성이 저하될 수 있다. 이러한 이중 구조의 은 선은 구리재료를 소정의 직경으로 인발하는 단계, 클래딩 공법(cladding process)에 의해 인발된 구리재료와 은 플레이트를 일체화시켜 상기 구리재료의 외부를 은 플레이트가 둘러싸는 이중 구조의 와이어를 얻는 단계 및 상기 이중 구조의 와이어를 신선 가공을 통해서 은 선을 얻는 단계를 포함하여 형성될 수 있다. 또는 상기 은 선은 인발된 구리재료 상에 액체형 Ag 파우더 용액이 담긴 용액을 처리해 상기 구리재료의 표면에 균일한 두께의 Ag를 코팅한 뒤, 신선가공을 통해서 은 선을 수득할 수도 있다. 또는 인발된 구리재료 상에 은을 도금하고, 이를 신선가공 처리하여 은 선을 수득할 수도 있다. The silver-containing fiber is a silver wire made of silver alone, a metal wire containing other metals such as copper in addition to silver, or a silver wire and/or a silver-containing metal wire braided with a conventional non-metal fiber. can be a speaker. When describing the metal wire containing other metals, such as copper, it may be linearly formed by mixing a metal other than silver in a non-solid state with silver, that is, in a non-solid state, ie, silver and non-alloy state. When a metal other than silver is mixed with silver in a non-solid state, the silver and the other metal may be arranged such that silver and other metal occupy a predetermined area regularly or irregularly in a single linear region, For example, it may have a double structure in which a layer is formed by enclosing silver on the outside of the copper wire. In this case, the copper wire may impart excellent flexibility to the silver wire, and the surrounding silver may have an average thickness of 3 to 3200 nm, and preferably, an average thickness of 5 to 3000 nm. If the average thickness of the surrounding silver is less than 3 nm, it is easy to manufacture so that copper, which is the central metal, is exposed to the outside, so that the antibacterial function may be lowered. There is a risk of being inhaled into the human respiratory tract or remaining on the skin. In addition, when the average thickness of the surrounding silver exceeds 3200 nm, the flexibility of the silver wire may be reduced. The double structure of the silver wire is a step of drawing a copper material to a predetermined diameter, integrating the copper material drawn by a cladding process and a silver plate to form a double structure in which the silver plate surrounds the outside of the copper material. It may be formed including the steps of obtaining a wire and obtaining a silver wire through wire drawing of the double-structured wire. Alternatively, the silver wire may be obtained by processing a solution containing a liquid Ag powder solution on the drawn copper material to coat Ag with a uniform thickness on the surface of the copper material, and then performing wire drawing to obtain the silver wire. Alternatively, silver wire may be obtained by plating silver on the drawn copper material and subjecting it to wire drawing.
다음으로 은 선이 비금속인 통상적인 섬유와 합사되어 형성한 실의 형태에 대해서 설명하면, 은 선과 통상적인 섬유는 2 종의 섬유를 합사하는 공지된 섬유분야의 제조방법, 공지된 2종 섬유의 배치구조를 적절히 채용하여 구현된 합연사일 수 있다. 이때, 사용된 은 선은 은으로만 이루어진 선이거나, 은과 다른 금속이 함유된 금속 선일 수 있다. 일예로, 상기 합연사는 심사, 상기 심사를 둘러싸는 은 선을 포함하는 제1커버링사, 및 상기 심사를 둘러싼 제1커버링사 외부를 둘러싸는 제2커버링사를 포함하는 3중 구조 단면을 갖는 실일 수 있다. Next, a description will be given of the form of a thread formed by braiding a silver wire with a non-metallic conventional fiber. The silver wire and the conventional fiber are a known manufacturing method in the field of textiles in which two kinds of fibers are braided, and the known two kinds of fibers. It may be a ply-twisted yarn implemented by appropriately adopting an arrangement structure. In this case, the silver wire used may be a wire made of only silver or a metal wire containing silver and other metals. For example, the ply-twisted yarn is a yarn having a triple structural cross section including a core yarn, a first covering yarn including a silver line surrounding the core, and a second covering yarn surrounding the outside of the first covering yarn surrounding the core yarn can
상기 심사 및 제2커버링사는 합연사의 유연성과 신축성을 향상시키는데 사용할 수 있는 섬유라면 제한 없이 사용할 수 있고, 바람직하게는 천연섬유 및 합성섬유 중에서 선택된 어느 하나 이상을 사용할 수 있고, 보다 바람직하게는 폴리에스테르계 섬유를 사용할 수 있다. 또한, 상기 심사 및 제2커버링사는 모노사 또는 다수 개의 필라멘트사로 형성될 수 있고, 바람직하게는 다수 개의 필라멘트사로 형성된 섬유일 수 있다. 또한, 상기 심사 및 제2커버링사는 당업계에서 통상적으로 사용할 수 있는 섬도의 섬유라면 제한 없이 사용할 수 있으며, 바람직하게는 각각 독립적으로 섬도가 20 ~ 100De'(데니어)일 수 있고, 보다 바람직하게는 섬도가 30 ~ 75De'일 수 있다. 만일 상기 심사 및 제2커버링사의 섬도가 각각 독립적으로 20De' 미만이면 은 선의 단사에 따른 항균성능 및 내구성이 저하될 수 있고, 섬도가 100De'를 초과하면 신축성이 저하되어 제1부재 등과 접합력이 저하되고, 이로 인해 계면분리가 발생할 우려가 있다. The core and second covering yarns may be used without limitation as long as they are fibers that can be used to improve the flexibility and elasticity of the ply-twisted yarn, and preferably, any one or more selected from natural fibers and synthetic fibers may be used, and more preferably poly Ester-based fibers may be used. In addition, the core yarn and the second covering yarn may be formed of a mono yarn or a plurality of filament yarns, and preferably a fiber formed of a plurality of filament yarns. In addition, the screening and second covering yarns may be used without limitation as long as they are fibers of fineness commonly used in the art, and preferably each independently may have a fineness of 20 to 100De' (denier), more preferably The fineness may be 30 ~ 75De'. If the fineness of the screening and the second covering yarn is independently less than 20De', the antibacterial performance and durability according to the single yarn of the silver wire may be reduced. and, thereby, there is a risk of interfacial separation.
또한, 상기 제2커버링사는 꼬임수 350 ~ 1100 TPM으로 연사될 수 있고, 바람직하게는 450 ~ 1000 TPM으로 연사되어 합연사에 포함될 수 있다. 만일 상기 제2커버링사의 꼬임수가 350 TPM 미만이면 내구성과 은 선의 단사에 따른 항균성능이 저하될 수 있다. 또한, 꼬임수가 1100 TPM을 초과하면 신축성 및 유연성이 저하될 수 있으며, 표면에 노출되는 은 선의 면적이 저하됨에 따라 상대적으로 항균성능이 저하될 수 있다.In addition, the second covering yarn may be twisted at a twist number of 350 to 1100 TPM, preferably twisted at 450 to 1000 TPM, and may be included in the ply-twisted yarn. If the number of twists of the second covering yarn is less than 350 TPM, the durability and antibacterial performance according to the single yarn of the silver wire may be deteriorated. In addition, when the number of twists exceeds 1100 TPM, elasticity and flexibility may be reduced, and as the area of the silver wire exposed to the surface decreases, the antibacterial performance may be relatively reduced.
한편, 제3부재(30)는 전술한 은으로 이루어진 은 선, 은을 포함하는 금속선 및/또는 합연사를 포함하여 다공성의 구조를 갖도록 구현된 부재로써, 이에 대한 구체적 예로서 직물, 편물, 부직포 또는 메쉬 시트일 수 있다. 이때, 상기 직물, 편물, 부직포 또는 메쉬시트는 은 선을 함유하지 않는 천염섬유 및/또는 합성섬유를 더 포함할 수도 있다. On the other hand, the third member 30 is a member implemented to have a porous structure including the above-mentioned silver wire made of silver, silver-containing metal wire and/or ply-twisted yarn, and specific examples thereof include fabric, knitted fabric, nonwoven fabric Or it may be a mesh sheet. In this case, the woven fabric, knitted fabric, nonwoven fabric or mesh sheet may further include natural fiber and/or synthetic fiber that does not contain a silver wire.
다음으로 다공성의 제4부재(40)에 대해 설명한다. 상기 제4부재(40)는 상술한 제1부재(20)의 일측에 배치되어 제1부재(20)를 보호하는 기능을 수행할 수 있다. 또한, 제3부재(30)가 더 포함되는 경우 제3부재(30)의 일측을 보호하는 기능을 수행할 수 있다. Next, the porous fourth member 40 will be described. The fourth member 40 may be disposed on one side of the above-described first member 20 to perform a function of protecting the first member 20 . In addition, when the third member 30 is further included, a function of protecting one side of the third member 30 may be performed.
상기 제4부재(40)는 여과될 외기가 1차로 통과하는 부재일 수 있으며, 이에 따라서 공기중의 미세입자에 대한 여과성능을 향상시키는 기능을 수행할 수 있다. 이를 위해 상기 제4부재(40)는 정전기력을 이용해서 공기 중에 포함된 미세먼지, 분진 등을 여과시키는 기능을 수행하는 다공성 부재일 수 있다. 상기 제4부재(40)는 일예로 공지된 부직포일 수 있으며, 바람직하게는 정전처리된 멜트블로운 부직포일 수 있다. 상기 정전처리는 다공성 부재 전체에 처리될 수 있으나, 일부에만 처리될 수 있음을 밝혀 두며, 통상적인 정전처리 필터의 제조 시 사용되는 공지된 방법을 적절히 채용할 수 있음에 따라서 이에 대한 구체적인 설명은 생략한다.The fourth member 40 may be a member through which external air to be filtered first passes, and thus may perform a function of improving filtration performance for fine particles in the air. To this end, the fourth member 40 may be a porous member performing a function of filtering fine dust, dust, etc. contained in the air using electrostatic force. The fourth member 40 may be, for example, a known nonwoven fabric, and preferably may be an electrostatically treated melt blown nonwoven fabric. The electrostatic treatment can be performed on the entire porous member, but it is revealed that only a part of it can be treated, and a detailed description thereof will be omitted because a known method used in the manufacture of a conventional electrostatic treatment filter can be appropriately employed. do.
또한, 목적에 따라서 적절히 제4부재(40)에 함유된 섬유의 직경, 평량을 조절할 수 있는데, 보다 향상된 여과성능, 내구성 등을 담보하기 위하여 상기 제4부재(40)는 직경이 1 ~ 10㎛인 섬유를 포함하며, 평량이 15 ~ 50g/㎡일 수 있고, 다른 일예로 평량은 20 ~35 g/㎡일 수 있다. 또한, 평균 공경은 20㎛이하일 수 있고, 다른 일예로 10㎛일 수 있다. 상기 제4부재(40)의 평균공경이 만일 과도하게 작을 경우 통기도가 저하되고, 압력손실이 증가할 수 있으며, 평균 공경이 과도하게 클 경우 여과효율이 저하될 수 있다. 또한, 제4부재(40)를 형성하는 섬유 평균직경이 과도하게 작을 경우 통기도가 저하되고, 압력손실이 증가할 수 있으며, 섬유 평균직경이 과도하게 클 경우 여과효율이 저하될 수 있다. 또한, 제4부재(40)의 평량이 과도하게 낮으면 편차가 커짐에 따라 여과효율이 저하되거나, 균일한 여과효율을 발현하지 못할 수 있으며, 과도하게 크면 통기도가 저하되고, 압력손실이 증가할 수 있다.In addition, the diameter and basis weight of the fibers contained in the fourth member 40 can be appropriately adjusted according to the purpose. In order to guarantee improved filtration performance and durability, the fourth member 40 has a diameter of 1 to 10 μm. Phosphorus fibers are included, and the basis weight may be 15 to 50 g/m 2 , and in another example, the basis weight may be 20 to 35 g/m 2 . In addition, the average pore diameter may be less than 20㎛, another example may be 10㎛. If the average pore diameter of the fourth member 40 is excessively small, air permeability may decrease and pressure loss may increase, and if the average pore diameter is excessively large, filtration efficiency may decrease. In addition, when the average diameter of the fibers forming the fourth member 40 is excessively small, air permeability may be reduced, pressure loss may increase, and if the average diameter of the fibers is excessively large, filtration efficiency may be reduced. In addition, if the basis weight of the fourth member 40 is excessively low, the filtration efficiency may be reduced as the deviation increases, or uniform filtration efficiency may not be expressed. can
또한, 상기 제4부재(40)를 형성하는 섬유는 폴리에스테르계, 폴리우레탄계, 폴리올레핀계 및 폴리아미드계로 이루어진 군에서 선택되는 합성고분자 성분; 또는 셀룰로오스계를 포함하는 천연 고분자성분을 포함할 수 있고, 일예로 폴리프로필렌을 포함할 수 있다.In addition, the fibers forming the fourth member 40 may include a synthetic polymer component selected from the group consisting of polyester, polyurethane, polyolefin, and polyamide; Or it may include a natural polymer component including a cellulose-based, for example, may include polypropylene.
한편, 제4부재(40)와 제1부재(20)가 조합된 항바이러스 필터여재의 경우 제1부재(20)와 함께 여과성능의 내구성 측면에서 상승작용을 발현한다. 구체적으로 상술한 제1부재(20)는 1㎛ 이하의 섬유가 축적되어 3차원 네트워크 구조를 형성한 것일 수 있다. 이때, 상기 제1부재(20)는 PM2.5 이하의 미세먼지까지 물리적으로 여과시킬 수 있는 공경을 갖도록 설계될 수 있고, 통과되는 공기의 유량 저하가 방지되도록 유로가 형성될 수 있다. 이때, 상기 제1부재(20)는 정전처리된 제4부재(40)에 발생할 수 있는 제전에 따른 포집효율 감소의 문제를 보완하며 장시간 초도 설계된 여과효율을 유지시키도록 기능할 수 있다. On the other hand, in the case of the antiviral filter medium in which the fourth member 40 and the first member 20 are combined, it exhibits a synergistic action in terms of durability of filtration performance together with the first member 20 . Specifically, the above-described first member 20 may have a three-dimensional network structure by accumulating fibers of 1 μm or less. In this case, the first member 20 may be designed to have a pore size capable of physically filtering fine dust of PM2.5 or less, and a flow path may be formed to prevent a decrease in the flow rate of air passing therethrough. In this case, the first member 20 may function to compensate for the problem of a reduction in collection efficiency due to static electricity that may occur in the electrostatically treated fourth member 40 and to maintain the initially designed filtration efficiency for a long time.
이를 도 6 내지 8을 참조하여 설명하면, 정전처리된 제4부재(40)는 정전기력을 이용해 분진을 섬유 표면에 흡착하는데, 시간이 경과할수록 정전기력이 감소하여 사용시간 5개월이 경과하면 여과효율이 초도 설계된 효율의 50% 이하로 저하되는데, 교체주기가 매우 짧은 문제가 있다. 그러나 도 8에 도시된 것과 같이 정전처리된 제4부재(40)와 함께 제1부재(20)를 사용 시 제4부재(40)만 사용되었을 때 포집효율이 계속 낮아지는 것과 달리 포집효율 저하가 적으며, 그래프에서 미도시 되었지만 수개월 지속하더라도 포집효율이 초도 설계된 수치의 95% 이상을 유지할 수 있는 이점이 있다. 6 to 8, the electrostatically treated fourth member 40 adsorbs dust to the fiber surface using electrostatic force, and as time elapses, the electrostatic force decreases. It is lowered to less than 50% of the initially designed efficiency, but there is a problem that the replacement cycle is very short. However, as shown in FIG. 8, when the first member 20 is used together with the electrostatically treated fourth member 40, when only the fourth member 40 is used, the collection efficiency continues to decrease, whereas the collection efficiency decreases. Although not shown in the graph, there is an advantage that the collection efficiency can be maintained at more than 95% of the initially designed value even if it continues for several months.
또한, 상술한 항바이러스 필터여재(100)는 도 10 및 도 11에 도시된 것과 일방향으로 교호적으로 배치되는 다수 개의 산과 골을 갖도록 절곡되어 에어필터 유닛(200)을 구현할 수 있다. 또한, 상기 에어필터 유닛(200)은 절곡된 항바이러스 필터여재(210)의 적어도 일측면, 바람직하게는 네 측면을 둘러싸도록 배치되어 항바이러스 필터여재(210)를 지지하고 에어필터 유닛의 형상을 유지시키는 필터프레임(220)을 더 포함할 수 있다. In addition, the above-described anti-viral filter media 100 may be bent to have a plurality of mountains and valleys alternately arranged in one direction as shown in FIGS. 10 and 11 to implement the air filter unit 200 . In addition, the air filter unit 200 is arranged to surround at least one side, preferably four sides, of the bent antiviral filter medium 210 to support the antiviral filter medium 210 and change the shape of the air filter unit. It may further include a filter frame 220 for maintaining.
또한, 상술한 항바이러스 필터여재(100) 또는 에어필터 유닛(200)은 각종 공지된 공조장치에 구비되는 에어필터를 대체해 사용될 수 있다. 상기 공조장치는 버스, 자가용 등의 차량이나 지하철, 기차 등의 운송수단이나, 각종 공공 건물 등에 구비되는 공조장치 또는, 각종 실내에 배치되는 공기청정기일 수 있으며, 공조장치에 항바이러스 기능이 구비된 필터여재를 구비함에 따라서 외부에서 유입되거나 또는 실내에서 순환되는 공기 중에 포함된 각종 세균이나 바이러스 등의 병원미생물을 여과시키거나 사멸시킬 수 있다. In addition, the antiviral filter media 100 or the air filter unit 200 described above may be used to replace the air filter provided in various known air conditioners. The air conditioner may be a vehicle such as a bus or private vehicle, a transportation means such as a subway or a train, an air conditioner provided in various public buildings, or an air purifier disposed in various indoor spaces, and the air conditioner has an antiviral function As the filter media is provided, it is possible to filter or kill pathogenic microorganisms such as various bacteria or viruses included in the air introduced from the outside or circulated in the room.
하기의 실시예를 통하여 본 발명을 더욱 구체적으로 설명하기로 하지만, 하기 실시예가 본 발명의 범위를 제한하는 것은 아니며, 이는 본 발명의 이해를 돕기 위한 것으로 해석되어야 할 것이다.The present invention will be described in more detail through the following examples, but the following examples are not intended to limit the scope of the present invention, which should be construed to aid understanding of the present invention.
<실시예1><Example 1>
두께 약 20㎛이며, 융점이 약 120℃인 폴리에틸렌을 초부로 하고, 폴리프로필렌을 심부로 하는 심초형 복합섬유로 형성된 부직포(㈜남양부직포, CCP30)인 제2부재 일면에 폴리아크릴로니트릴(PAN)인 섬유형성성분을 포함하는 방사용액을 전기방사 시킨 뒤 140℃의 온도로 열 및 1kgf/㎠ 압력을 가해 캘린더링 공정을 수행하여 PAN 나노섬유웹인 제1부재와 제2부재간 융착시킨 필터여재를 제조하였다. 이때, PAN 나노섬유웹은 섬유의 평균직경이 0.2㎛이며, 평량이 20g/㎡이고, 평균공경이 1㎛이었다. Polyacrylonitrile (PAN) on one side of the second member, which is a nonwoven fabric (Namyang Nonwoven Co., Ltd., CCP30) formed of a core-sheath composite fiber having a thickness of about 20 μm and a melting point of about 120°C as a sheath and polypropylene as a core. ) after electrospinning a spinning solution containing a fiber-forming component, heat and 1 kgf/cm 2 pressure at a temperature of 140° C. A filter media was prepared. At this time, the PAN nanofiber web had an average diameter of fibers of 0.2 μm, a basis weight of 20 g/m 2 , and an average pore diameter of 1 μm.
준비된 필터여재를 0.1중량% 농도로 소듐 라우릴 설페이트인 음이온성 계면활성제가 용해된 수용액인 항바이러스 코팅용액에 침지시킨 뒤, 꺼내고 나서 캘린더링을 통과시켜서 과량의 코팅용액을 제거시킨 뒤 70℃온도로 건조시켜서 하기 표 1과 같은 항바이러스 필터여재를 제조하였다.After immersing the prepared filter media in an antiviral coating solution, which is an aqueous solution in which an anionic surfactant, sodium lauryl sulfate, is dissolved at a concentration of 0.1% by weight, take it out and pass it through calendering to remove the excess coating solution and then at a temperature of 70°C. and dried to prepare antiviral filter media as shown in Table 1 below.
<실시예2 ~ 6><Examples 2 to 6>
실시예1과 동일하게 실시하여 제조하되, 계면활성제의 종류 및/또는 농도를 하기 표 1과 같이 변경해 하기 표 1과 같은 항바이러스 필터여재를 제조했다. It was prepared in the same manner as in Example 1, except that the type and/or concentration of the surfactant was changed as shown in Table 1 below to prepare antiviral filter media as shown in Table 1 below.
<비교예1><Comparative Example 1>
실시예1과 동일하게 실시하여 제조하되, 항바이러스 코팅용액을 처리하지 않고, 준비된 필터여재를 사용하였다.It was prepared in the same manner as in Example 1, but the antiviral coating solution was not treated, and the prepared filter media was used.
<실험예><Experimental example>
실시예 및 비교예1에 따른 필터여재에 하기의 물성을 평가하여 그 결과를 하기 표 1에 나타내었다.The following physical properties were evaluated for the filter media according to Examples and Comparative Example 1, and the results are shown in Table 1 below.
1. 항바이러스 성능A1. Antiviral Performance A
시편을 가로 4㎝, 세로 4㎝가 되도록 준비했다. 이후 PED 바이러스(coronaviridae, Enveloped RNA virus) 200㎕를 각 시편 상에 처리한 뒤 23℃ 온도에서 14시간 정치 후 시편에 1X DMEM(0.3% Tryptose Phosphate Broth, 0.02%Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin)인 접종용 배지 800㎕를 첨가하여 시편 상에 위치했던 바이러스를 회수했다. The specimen was prepared to be 4 cm wide and 4 cm long. After that, 200 μl of PED virus (coronaviridae, Enveloped RNA virus) was treated on each specimen, and after standing at 23° C. for 14 hours, 1X DMEM (0.3% Tryptose Phosphate Broth, 0.02% Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin), 800 μl of an inoculation medium was added to recover the virus located on the specimen.
회수된 바이러스를 함유한 접종용 배지를 10진 희석한 후 희석 배수당 100㎕씩 5웰에 접종한 후 CO2 인큐베이터에서 1시간 흡착 후 inoculum을 제거하고 바이러스 배양용 배지를 이후 VERO세포가 2×104 개/well로 함유된 96-웰플레이트에 well당 200㎕씩 분주하고 5일간 인큐베이터에서 배양했다. 이후 세포의 CPE를 확인하고 TCID값을 계산했고, 그 결과값을 하기 표 1에 나타내었다.After 10 dilutions of the inoculation medium containing the recovered virus, 100 μl of each dilution factor was inoculated into 5 wells. After adsorption in a CO 2 incubator for 1 hour, the inoculum was removed, and the virus culture medium was then incubated with 2× VERO cells. 200 μl per well was dispensed in a 96-well plate containing 10 4 pieces/well and cultured in an incubator for 5 days. Thereafter, the CPE of the cells was checked and the TCID value was calculated, and the results are shown in Table 1 below.
바이러스 역가는 TCID값이 5.0000 이었고, 양성대조군은 바이러스 원액만을 200㎕ 23℃ 온도에서 14시간 정치 후 접종용 배지를 동일하게 처리하여 평가한 결과이며, TCID값이 5.0000 이었다.The virus titer had a TCID value of 5.0000, and the positive control group was evaluated by treating only the virus stock solution at 200 μl 23° C. for 14 hours and then treating the inoculation medium in the same way, and the TCID value was 5.0000.
2. 항바이러스 성능B2. Antiviral performance B
시편을 가로 4㎝, 세로 4㎝가 되도록 준비했다. 준비된 시편을 1.5ml tube 위에 올려둔 후 PED 바이러스를 각각 200㎕씩 시편 상에 처리한 뒤 23℃에서 원심분리하였다. 이후 원심분리 해 수득한 바이러스에 1X DMEM(0.3% Tryptose Phosphate Broth, 0.02%Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin)인 접종용 배지 800㎕를 첨가한 뒤 10진 희석 후 항바이러스 성능A 평가와 동일하게 수행하여 세포의 CPE를 확인하고 TCID값을 계산했고, 그 결과값을 하기 표 1에 나타내었다. 이때 사용된 바이러스 역가는 TCID값이 5.0000 이었다.The specimen was prepared to be 4 cm wide and 4 cm long. After the prepared specimen was placed on a 1.5ml tube, 200 μl of each PED virus was treated on the specimen and centrifuged at 23°C. After centrifugation, 800 μl of inoculation medium containing 1X DMEM (0.3% Tryptose Phosphate Broth, 0.02% Yeast Extract, 1% antibiotic-antimycotic, 5ug/ml trypsin) was added to the virus obtained by centrifugation, followed by decimal dilution and antiviral performance In the same manner as in evaluation A, the CPE of the cells was checked and the TCID value was calculated, and the results are shown in Table 1 below. The virus titer used at this time had a TCID value of 5.0000.
3. 공기투과도 3. Air permeability
공기투과도는 공기투과도 시험기(Air Permeability Tester, TEXTEST)에 필터여재를 장착해 모두 동일한 조건에서 측정하였다. 측정된 결과에 대해서 비교예1의 공기투과도를 100%로 기준해 나머지 실시예들의 공기투과도를 상대적인 백분율로 나타내었다. 백분율이 0에 가까울수록 공기투과도의 변동이 큰 것을 의미한다.The air permeability was measured under the same conditions by installing a filter medium in an air permeability tester (TEXTEST). With respect to the measured results, the air permeability of the other examples was expressed as a relative percentage based on the air permeability of Comparative Example 1 as 100%. The closer the percentage is to 0, the greater the fluctuation in air permeability.
실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4 실시예5Example 5 실시예6Example 6 비교예1Comparative Example 1
계면활성제(종류/농도(중량%)Surfactant (type/concentration (wt%) A/0.1A/0.1 B/0.1B/0.1 A/0.3 +
B/0.3
A/0.3 +
B/0.3
A/0.08A/0.08 A/0.98A/0.98 A/1.2A/1.2 미처리 unprocessed
항바이러스 성능ATCID50(log10)Antiviral performanceATCID50 (log 10 ) 0.5630.563 0.5810.581 0.8960.896 1.5511.551 0.4320.432 0.4250.425 4.9904.990
항바이러스성능BTCID50(log10)Antiviral performanceBTCID50 (log 10 ) 3.5003.500 3.5583.558 4.0004.000 4.8404.840 3.2253.225 3.2203.220 5.0005.000
공기투과도air permeability 95.695.6 95.595.5 90.390.3 98.598.5 85.085.0 53.353.3 100100
표 1에서 A는 소듐 라우릴 설페이트인 음이온성 계면활성제이며, B는 세틸 트리메틸아모늄 브로마이드인 양이온성 계면활성제이다.In Table 1, A is an anionic surfactant that is sodium lauryl sulfate, and B is a cationic surfactant that is cetyl trimethylamonium bromide.
표 1을 통해 확인할 수 있듯이, As can be seen from Table 1,
항바이러스 성능A 결과 실시예1, 2, 4, 5는 99.0% 이상의 바이러스 제거성능이 있는 것을 확일 수 있다. 또한, 항바이러스 성능B 결과 실시예1, 2, 4, 5는 90.0% 이상의 바이러스 제거성능이 있는 것을 알 수 있다. As a result of antiviral performance A, it can be confirmed that Examples 1, 2, 4, and 5 have virus removal performance of 99.0% or more. In addition, as a result of antiviral performance B, it can be seen that Examples 1, 2, 4, and 5 had a virus removal performance of 90.0% or more.
한편, 계면활성제의 농도가 과도한 실시예6의 경우 공기투과도의 저해가 심한 것을 알 수 있다.On the other hand, in the case of Example 6 in which the concentration of the surfactant is excessive, it can be seen that the air permeability is severely inhibited.
이상에서 본 발명의 일 실시예에 대하여 설명하였으나, 본 발명의 사상은 본 명세서에 제시되는 실시 예에 제한되지 아니하며, 본 발명의 사상을 이해하는 당업자는 동일한 사상의 범위 내에서, 구성요소의 부가, 변경, 삭제, 추가 등에 의해서 다른 실시 예를 용이하게 제안할 수 있을 것이나, 이 또한 본 발명의 사상범위 내에 든다고 할 것이다.Although one embodiment of the present invention has been described above, the spirit of the present invention is not limited to the embodiments presented herein, and those skilled in the art who understand the spirit of the present invention can add components within the scope of the same spirit. , changes, deletions, additions, etc. may easily suggest other embodiments, but this will also fall within the scope of the present invention.

Claims (16)

  1. 계면활성제를 포함하는 항바이러스 성분을 구비한 섬유들로 형성된 제1부재;를 포함하는 항바이러스 필터여재.An antiviral filter medium comprising a; a first member formed of fibers having an antiviral component including a surfactant.
  2. 제1항에 있어서,According to claim 1,
    상기 계면활성제는 섬유 표면 상에 노출되도록 구비되는 항바이러스 필터여재.The surfactant is an antiviral filter media provided to be exposed on the fiber surface.
  3. 제1항에 있어서, According to claim 1,
    상기 항바이러스 성분은 항바이러스 성분을 포함하는 코팅용액을 제1부재 상에 처리하여 항바이러스 성분이 섬유 상에 구비되거나, 또는The antiviral component is treated with a coating solution containing an antiviral component on the first member so that the antiviral component is provided on the fiber, or
    상기 제1부재를 형성하기 위한 전기방사용액에 항바이러스 성분이 구비되어 섬유 상에 구비되는 항바이러스 필터여재.An antiviral filter medium provided on a fiber with an antiviral component in the electrospinning solution for forming the first member.
  4. 제1항에 있어서,According to claim 1,
    상기 제1부재를 형성하는 섬유의 평균직경은 0.05 ~ 1㎛이고, 평량은 2g/㎡ 이하, 평균공경은 3㎛ 이하인 것을 특징으로 하는 항바이러스 필터여재.The average diameter of the fibers forming the first member is 0.05 ~ 1㎛, the basis weight is 2g / m2 or less, the average pore diameter is 3㎛ or less antiviral filter media.
  5. 제1항에 있어서,According to claim 1,
    상기 계면활성제는 양이온성 계면활성제 및 음이온성 계면활성제 중 어느 하나 이상을 포함하는 항바이러스 필터여재.The surfactant is an antiviral filter medium comprising at least one of a cationic surfactant and an anionic surfactant.
  6. 제1항에 있어서,According to claim 1,
    상기 항바이러스 성분은 항바이러스 성분을 포함하는 코팅용액이 제1부재 상에 처리되어 항바이러스 성분이 섬유 상에 구비되며, The antiviral component is a coating solution containing an antiviral component is treated on the first member, the antiviral component is provided on the fiber,
    상기 코팅용액 내 상기 계면활성제는 0.1 ~ 1중량% 농도로 구비되는 것을 특징으로 하는 항바이러스 필터여재.The antiviral filter media, characterized in that the surfactant in the coating solution is provided at a concentration of 0.1 to 1% by weight.
  7. 제5항에 있어서,6. The method of claim 5,
    상기 양이온성 계면활성제는 세틸 트리메틸아모늄 브로마이드(Cetyl trimethylammonium bromide)를 포함하고, 상기 음이온성 계면활성제는 소듐 라우릴설페이트(Sodium Lauryl Sulfate)를 포함하는 항바이러스 필터여재.The cationic surfactant includes cetyl trimethylammonium bromide, and the anionic surfactant includes sodium lauryl sulfate.
  8. 제1항에 있어서,According to claim 1,
    상기 제1부재 일측에 배치되며, 지지기능을 수행하는 다공성의 제2부재를 더 포함하는 항바이러스 필터여재.The antiviral filter media further comprising a porous second member disposed on one side of the first member and performing a supporting function.
  9. 제8항에 있어서,9. The method of claim 8,
    상기 제2부재는 직경이 30 ~ 50㎛인 열융착성 섬유를 포함하며, 평량이 30 ~ 100g/㎡인 부직포인 항바이러스 필터여재.The second member includes a heat-sealable fiber having a diameter of 30 to 50 μm, and an antiviral filter medium having a basis weight of 30 to 100 g/m 2 .
  10. 제9항에 있어서,10. The method of claim 9,
    상기 열융착성 섬유는 폴리에틸렌을 구비하는 초부 및 상기 초부 보다 융점이 높은 폴리프로필렌을 구비하는 심부로 형성된 심초형 복합섬유인 항바이러스 필터여재.The heat-sealable fiber is an antiviral filter media that is a core-sheath type composite fiber formed of a sheath comprising polyethylene and a core comprising polypropylene having a higher melting point than the sheath.
  11. 제1항에 있어서,According to claim 1,
    은을 함유하는 섬유로 형성된 직물, 편물, 부직포 또는 메쉬 시트인 다공성의 제3부재 및 정전처리된 멜트블로운 부직포인 제4부재 중 어느 하나 이상을 더 포함하는 항바이러스 필터여재.Antiviral filter media further comprising any one or more of a porous third member that is a woven, knitted, nonwoven, or mesh sheet formed of silver-containing fibers and a fourth member that is electrostatically treated melt blown nonwoven fabric.
  12. 제11항에 있어서, 12. The method of claim 11,
    상기 제3부재는 은 선을 포함하는 합연사를 통해 형성되며, 상기 합연사는 심사, 상기 심사를 둘러싸는 은 선을 포함하는 제1커버링사, 및 상기 심사를 둘러싼 제1커버링사 외부를 둘러싸는 제2커버링사를 포함하는 것을 특징으로 하는 항바이러스 필터여재. The third member is formed of a ply-twisted yarn including a silver wire, and the ply-twisted yarn includes a core, a first covering yarn including a silver line surrounding the core, and the outside of the first covering yarn surrounding the core. Antiviral filter media comprising a second covering yarn.
  13. 제11항에 있어서,12. The method of claim 11,
    상기 제4부재는 직경이 1 ~ 10㎛인 폴리프로필렌 섬유를 포함하며, 평량이 15 ~ 50g/㎡인 항바이러스 필터여재.The fourth member includes polypropylene fibers having a diameter of 1 to 10 μm, and an antiviral filter medium having a basis weight of 15 to 50 g/m 2 .
  14. 제11항에 있어서,12. The method of claim 11,
    지지기능을 수행하는 다공성의 제2부재가 제1부재 일측에 더 구비되며, A porous second member performing a supporting function is further provided on one side of the first member,
    상기 제1부재 일측에 대향하는 타측에 제3부재 및 제4부재 순서로 배치되는 항바이러스 필터여재.An antiviral filter medium disposed in order of a third member and a fourth member on the other side opposite to one side of the first member.
  15. 일 방향으로 산과 골이 교호적으로 형성되도록 절곡된 제1항 내지 제14항 중 어느 한 항에 따른 항바이러스 필터여재; 및The antiviral filter media according to any one of claims 1 to 14, which is bent so that mountains and valleys are alternately formed in one direction; and
    상기 항바이러스 필터여재를 둘러싸는 필터프레임;을 포함하는 에어필터 유닛.An air filter unit comprising a; a filter frame surrounding the antiviral filter medium.
  16. 제1항 내지 제14항 중 어느 한 항에 따른 항바이러스 필터여재를 포함하는 공조장치.An air conditioner comprising an antiviral filter medium according to any one of claims 1 to 14.
PCT/KR2021/004826 2020-04-16 2021-04-16 Antiviral filter medium, and air filter unit and air conditioner including same WO2021210956A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20200046319 2020-04-16
KR20200046320 2020-04-16
KR10-2020-0046320 2020-04-16
KR10-2020-0046319 2020-04-16

Publications (1)

Publication Number Publication Date
WO2021210956A1 true WO2021210956A1 (en) 2021-10-21

Family

ID=78084705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/004826 WO2021210956A1 (en) 2020-04-16 2021-04-16 Antiviral filter medium, and air filter unit and air conditioner including same

Country Status (2)

Country Link
KR (1) KR102587194B1 (en)
WO (1) WO2021210956A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001162116A (en) * 1999-12-06 2001-06-19 Japan Vilene Co Ltd Antibacterial treatment method and antibacterial filter medium
KR20020020382A (en) * 2000-09-08 2002-03-15 이충중 electric cartridge filter and manufacturing method of the same
KR20040092901A (en) * 2003-04-29 2004-11-04 주식회사 대우일렉트로닉스 Filter having function of deodorizaton, removal of germ and dehumidification
WO2012123446A1 (en) * 2011-03-15 2012-09-20 Glaxo Group Limited Filter material and face mask against pathogens
KR20200033669A (en) * 2018-09-20 2020-03-30 주식회사 엘지화학 Filter media for electret filter comprising nano fiber sheet and manufacturing methode of the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63143918A (en) * 1986-12-05 1988-06-16 Matsushita Electric Ind Co Ltd Nonwoven fabric for air filter
KR20020028091A (en) 2000-10-06 2002-04-16 오원춘 Plated and activated carbon fiber having improved antibacterial characteristics and its manufacturing method
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations
CZ297697B6 (en) * 2005-11-10 2007-03-07 Elmarco, S. R. O. Filter for removing physical and/or biological contaminants
KR101209848B1 (en) * 2010-06-18 2012-12-07 주식회사 아모그린텍 Ag ply yarn, functional fabric using the same and manufacturing method thereof
JP7032905B2 (en) * 2017-10-18 2022-03-09 スターライト工業株式会社 Laminated body and filter media using it

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001162116A (en) * 1999-12-06 2001-06-19 Japan Vilene Co Ltd Antibacterial treatment method and antibacterial filter medium
KR20020020382A (en) * 2000-09-08 2002-03-15 이충중 electric cartridge filter and manufacturing method of the same
KR20040092901A (en) * 2003-04-29 2004-11-04 주식회사 대우일렉트로닉스 Filter having function of deodorizaton, removal of germ and dehumidification
WO2012123446A1 (en) * 2011-03-15 2012-09-20 Glaxo Group Limited Filter material and face mask against pathogens
KR20200033669A (en) * 2018-09-20 2020-03-30 주식회사 엘지화학 Filter media for electret filter comprising nano fiber sheet and manufacturing methode of the same

Also Published As

Publication number Publication date
KR102587194B1 (en) 2023-10-11
KR20210128364A (en) 2021-10-26

Similar Documents

Publication Publication Date Title
WO2021045561A1 (en) Vibration-proof net for blocking fine dust
WO2016195287A1 (en) Mask having adsorption membrane provided therein
CN111235756B (en) Novel dustproof, antibacterial and antiviral nanofiber mask
WO2019177289A1 (en) Multilayer planar filter having visible light transmittance and high durability, for blocking fine particles by simultaneously applying electrostatic collection and physical collection, and manufacturing method therefor
WO2021015554A1 (en) Filter medium and composite filter including same
EP1953286A1 (en) Fabric and mask
KR20080071583A (en) Filter for removing of physical and/or biological impurities
WO2018199579A2 (en) Antibacterial copper filter using antibacterial copper net
KR20110023683A (en) Functional materials-introduced protective fabric for adsorption-removal of chemical warfare agents and method of preparing the same and protective clothes for adsorption-removal of chemical warfare agents using the same
CN101563486A (en) Polyethylenimine nanoparticle-containing microbicidal electrospun polymer fibers for textile applications
WO2022145604A1 (en) Washable fine dust filter module using nanofibers
CN112721361A (en) Polyimide fiber repeatable medical protective clothing material and preparation method thereof
WO2017047980A1 (en) Photocatalyst functional nonwoven fabric, and method for producing same
WO2021210956A1 (en) Antiviral filter medium, and air filter unit and air conditioner including same
KR20040098594A (en) Dustproof clothing
CN111729119A (en) Air purification assembly with coronavirus killing function and application thereof
WO2022080561A1 (en) Multi-layer knitted fabric having improved electrostatic filter properties, and uses thereof
WO2021235903A1 (en) Antiviral filter medium, and air filter unit and air conditioner including same
CN217287610U (en) Air filtering material based on nanofiber
CN213404957U (en) Mask
WO2021101215A1 (en) Air purifying filter
CN114347620A (en) Preparation of biodegradable fiber mask with one-way moisture-conducting function
WO2022039384A1 (en) Mask and manufacturing method thereof
WO2021002679A1 (en) Antibacterial composition, filter using same, and home appliance comprising filter
CN113322534A (en) Modified fiber, preparation method thereof and medical protective clothing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21787833

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21787833

Country of ref document: EP

Kind code of ref document: A1